Stock Market Today 10.01.2026

CAPM:CA AI-Generated Signals, Neutral Ratings; Trading Plans

January 10, 2026, 4:08 PM EST. On January 10, 2026, AI-generated signals for Capital Group Multi-Sector Income Select ETF (Canada) CAPM:CA show two tactical setups. A long entry near 24.85 with a target of 25.14 and a stop at 24.73; a short entry near 25.14 with a target of 24.85 and a stop at 25.27. The AI ratings span Near, Mid and Long horizons, all Neutral. The timestamp is 02:43 PM ET, with updated signals available for review. The note references CAPM:CA and a chart link. Brief glossary: an ETF (exchange-traded fund) is a fund that trades on an exchange like a stock and holds a basket of assets. Traders should verify data before acting.

Victrex (LSE: VCT) fair value trimmed as mixed analyst views and leadership transition unfold

January 10, 2026, 4:07 PM EST. Victrex' latest research update trims the fair value estimate, lowering the model multiple from 7.79x to 7.48x and nudging the discount rate from 7.65% to 7.69%. The shift mirrors a cautious market stance and mixed analyst views on the European chemicals space. On the bullish side, Morgan Stanley maintains an Overweight rating with a 940 GBp target, still above the trimmed fair value ascribed by the model, signaling confidence in execution and longer-term growth. On the bearish side, Barclays moves Victrex to Equal Weight, citing sector headwinds and a preference for other sub-sectors within chemicals. Separately, James Routh will become CEO on 1 January 2026, joining the board the same day; incumbent Jakob Sigurdsson transitions out by February 6, 2026.

Buenaventura valuation in focus after momentum; fair value pegged at $27.17

January 10, 2026, 4:06 PM EST. BVN has drawn fresh attention after a rally, with double-digit gains over the last month and quarter. The stock trades at $32.20 with a fair value of $27.17 and an estimated 8% intrinsic discount. The setup suggests momentum that could outpace fundamentals. The market narrative flags BVN as overvalued versus that fair value as investors watch catalysts. The focus is the San Gabriel project, due to start gold production in Q4 2025 and ramp in 2026, boosting gold output and diversification amid macro uncertainty. On earnings, BVN trades at a P/E of 18.8x vs a fair 21.2x, with peers around 29x and the US Metals & Mining index near 27.2x. Risks include higher capex and sensitivity to gold, silver, and copper prices. Momentum vs value remains the key question.

Ark Invest trims Palantir stake, boosts Broadcom and Joby bets as AI and defense themes persist

January 10, 2026, 4:03 PM EST. Ark Invest sold 58,741 shares of Palantir via ARKW for about $10.4 million amid defense-budget chatter. Palantir closed at $176.86, down 2.65%. The firm also bought 31,573 Broadcom shares, roughly $10.4 million, after a strong Q4 showing; Broadcom finished near $332.48, down 3.21%. In a separate move, ARKX purchased 162,270 shares of Joby Aviation for about $2.5 million, aligned with Joby plan to expand manufacturing in Ohio to four aircraft per month by 2027. The Palantir trade coincided with a Cramer post, feeding market chatter about the stock's trajectory. Analysts weigh AI and semiconductor dynamics as Ark positions around defense-related themes.

Masimo valuation under review after rebound; longer-term headwinds persist

January 10, 2026, 3:49 PM EST. Masimo (MASI) shares hovered around $138.92 after a 9.0% 7-day gain, yet a -16.5% 1-year TSR and a -46.9% 5-year TSR underscore a mixed longer-term view. Analyst targets sit near $183.75, with a reported narrative fair value of $183.13, suggesting the market may be pricing in only modest upside beyond potential earnings and margin improvements. The stock trades about 3.4x P/S versus a sector average of 3.3x and peers at 6.1x; Simply Wall St's fair multiple is 1.5x P/S, hinting toward valuation risk if the market reverts. Forward drivers include AI-enabled next-gen monitors and advanced sensors that could support premium pricing and margin expansion as hospitals demand multiparameter solutions. Risks include margin gains and execution in wearables and telemonitoring.

Coeur Mining Valuation Under Review After Momentum Run

January 10, 2026, 3:47 PM EST. Coeur Mining (CDE) trades at 20.40 after a 7-day gain of 16.24% and a 30-day gain of 27.74%, part of a broader rerating tied to the Rochester and Las Chispas ramp ups. A narrative fair value sits near 21.29, signaling the stock as UNDERVALUED. The shares trade at about 32.1x earnings, above peers at 25.7x and the wider US Metals and Mining group at 27.8x, with a fair multiple around 26.7x. If the production ramp and margins hold, upside could unfold; downside risks include regulatory delays on Silvertip and exploration shortfalls that fail to replace reserves. The analysis lays out the assumptions behind the forecasts and how they connect to the current price.

Cramer on CrowdStrike After Jensen Huang Endorsement; Stock Off November Highs

January 10, 2026, 3:34 PM EST. CrowdStrike Holdings Inc. (CRWD) provides cloud-based cybersecurity for endpoints, cloud systems, identities and data. Jim Cramer on Squawk on the Street noted the stock had fallen sharply from its November highs, a point he confirmed after reviewing the latest research. While the section acknowledged CrowdStrike's potential, it argued certain AI stocks may offer greater upside with less downside risk. The note also references the onshoring trend and tariffs as catalysts for select tech names. Original reporting: Insider Monkey.

Truist lifts Teva PT to $36; S&P upgrades Teva credit rating to BB+

January 10, 2026, 3:33 PM EST. Truist lifted Teva Pharmaceutical Industries' price target to $36 from $32 on January 7, maintaining a Buy rating as the bank argues the affordable medicines theme remains attractive into 2026. In a separate note, S&P Global Ratings upgraded Teva's long-term issuer credit rating to BB+ with a stable outlook, while Moody's affirmed a B1 rating with a positive outlook. S&P said Teva's adjusted leverage declined to 4.4x as of September 30, 2025 and is seen dipping below 4.25x in coming quarters to reach the higher rating. The agency cited business strength, liquidity, and progress toward revenue growth from branded medicines and stabilized generics. Teva operates US, Europe, and International Markets segments across the portfolio of specialty, generics, and OTC products.

Wolfe Downgrades AbbVie to Peer Perform; UBS Lifts Target; AbbVie Denies Revolution Medicines Talks

January 10, 2026, 3:32 PM EST. Wolfe Research downgraded AbbVie (ABBV) to Peer Perform from Outperform on January 8, saying the shares already reflect gains from Skyrizi and Rinvoq and it seeks higher visibility on the immunology encore and competitive dynamics. The firm did not publish a new price target. In a separate note, Reuters reported AbbVie denied involvement in talks to acquire Revolution Medicines, after The Wall Street Journal cited advanced discussions. UBS started coverage with a Neutral rating and lifted the target to $240 from $220, saying the stock is fairly priced and risks/rewards look balanced as competition emerges for its immunology drugs in 2026-27. AbbVie remains a research-based pharmaceutical company with products across oncology, gastroenterology, rheumatology, dermatology, virology and more.

Biogen targets rise as Goldman, Mizuho lift; Truist holds; 2026 momentum eyed

January 10, 2026, 3:31 PM EST. Biogen (BIIB) has been among the best-performing pharma stocks in 2025. On January 8, analysts from Truist, Goldman Sachs and Mizuho issued updates. Truist raised its price target to $190 from $142 and kept a Hold rating, saying the updated model hasn't changed the fundamental view. Goldman Sachs lifted its target to $225 from $197 and kept a Buy rating, expecting 2026 momentum driven by stronger fundamentals, favorable market dynamics and easing policy risk, with M&A tailwinds. Mizuho increased its target to $207 from $177 and maintained an Outperform rating, noting 2026 looks better after updating the model. Biogen's portfolio spans TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA; SPINRAZA for SMA and SKYCLARYS for Friedreich's Ataxia.

Sterling Infrastructure appears fairly valued after multi-year surge, DCF suggests narrow gap

January 10, 2026, 3:30 PM EST. Sterling Infrastructure shares closed at $308.13, down 3.5% over the past week, 7.1% in the last month, and 3.5% year to date. The stock has posted a 1-year return of 88.4% amid a longer run of gains in the infrastructure and capital goods sector. The valuation score stands at 4 out of 6 in the current framework. A Discounted Cash Flow (DCF) analysis, using a trailing twelve months free cash flow of about $353.7 million and projections through 2035, yields an intrinsic value around $313.26 per share. At $308.13, the stock appears about 1.6% undervalued and roughly fair to current prices. The P/E ratio is about 30x, near peer multiples, suggesting no clear mispricing but room for movement with changing fundamentals.

Grayscale Delves into BNB, HYPE Trusts as DeepSnitch AI Rises

January 10, 2026, 2:46 PM EST. Grayscale registered Delaware statutory trusts linked to Binance Coin (BNB) and HYPE, a move seen as administrative groundwork ahead of potential ETF filings. It does not guarantee approvals, but it keeps institutional attention on non-Bitcoin assets. Traders rotate capital toward assets with broad appeal, a dynamic that can lift sentiment for the best crypto to buy now. DeepSnitch AI has joined the conversation with live tools, ongoing updates, and rising presale interest. The project has raised over $1.1 million and the token is up about 121% since kickoff, with listing rumors fueling speculation of 100x gains. AI snitches (three live), a dashboard, security audits, and plain-language risk context via SnitchGPT are part of the design. It also offers uncapped staking, potentially attractive after rate cuts.

Citizens Downgrades Life360 to Market Perform on 2026 Growth Skepticism; Nativo Acquisition Closes

January 10, 2026, 2:45 PM EST. Citizens downgraded Life360 (LIF) to Market Perform from Outperform, citing skepticism over 2026 growth catalysts after a deceleration in core growth and difficult year-over-year comparisons from the 2025 US advertising push. Domestic price increases look unlikely until a meaningful new feature update. On the same day, Life360 announced the completion of its $120 million acquisition of Nativo, financed with 65% cash and 35% stock, integrating Nativo's ad tech and publisher network to form a larger first-party platform across the Life360 app, Connected TV, mobile and other digital channels. Earlier in December, DA Davidson started coverage with a Buy rating and a $94 price target, calling for international MAU growth and higher-margin revenue from pet GPS subscriptions.

BofA Keeps Underperform on GoodRx, Trims Target to $2.60 (GDRX)

January 10, 2026, 2:44 PM EST. Bank of America keeps an Underperform rating on GoodRx Holdings Inc. (GDRX) and trims its price target to $2.60 from $3, effective Jan. 5. The view labels the stock oversold but less appealing against peers. Separately, Morgan Stanley cut its GoodRx target to $4 from $5 while keeping an Equal Weight rating, part of a 2026 healthcare-services outlook that cites headwinds in managed care. On Dec. 8, Barclays initiated coverage with an Underweight stance and a $3 target, signaling a cautious view on drug distributors versus other US healthcare tech and distribution subsectors. GoodRx provides information and tools to compare prescription prices in the US. The report's broader tone notes AI stocks offering greater upside in some risk scenarios.

Cramer highlights CoreWeave IPO surge, pullback for CRWV

January 10, 2026, 2:43 PM EST. Jim Cramer revisited CoreWeave on his show, noting a volatile path for its stock (ticker CRWV). The data-center operator priced at $40, surged to about $187 in June, then traded near $77. He warned investors to cool enthusiasm after outsized gains and noted that peers moved higher too. CoreWeave runs a cloud platform for GenAI (generative artificial intelligence) workloads, providing compute, storage, networking and managed services. While acknowledging potential in AI infrastructure, he suggested some AI stocks offer greater upside with less downside risk. The backdrop includes tariff-era sentiment and onshoring trends that can sway valuations. This summary reflects public remarks; no investment recommendation is implied.

VOO: The Easiest Path to a $1 Million Portfolio in 2026

January 10, 2026, 2:29 PM EST. Investing for a million-dollar portfolio doesn't require stock-picking genius. The piece argues that a simple, disciplined approach beats chasing moonshots. The path: buy the Vanguard S&P 500 ETF (VOO) – a fund that tracks the S&P 500 index, the benchmark trusted by pros and retail investors alike. Fees are low. Historically, many active managers fail to beat the index; about 86% underperformed over the last five years, per S&P Global. A steady, monthly commitment of $5,000 into VOO can compound toward seven figures over time, without needing to outsmart the market. By contrast, a one-off pick like Nvidia in 2016 might have looked promising, but a regular VOO plan with continued contributions largely achieves the goal.

Bank of America dividend could target $500 monthly ahead of Q4 earnings

January 10, 2026, 2:28 PM EST.Bank of America enters its Q4 report with a dividend focus. Analysts expect Q4 earnings of 96 cents per share and revenue of $27.62 billion, according to Benzinga Pro. The stock yields about 1.99% with a $1.12 annual dividend ($0.28 quarterly). To target $6,000 a year from dividends would require about 5,357 shares, roughly $300,000 at current prices; for $1,200 annually, about 1,071 shares. The math rests on the assumption the $1.12 annual payout holds. Dividend yield shifts as both price and payments move: higher prices trim yield, lower prices lift it. Investors should monitor both the dividend and BAC's stock price around the earnings release.

Pinterest appears undervalued after price weakness; DCF signals a 47% discount

January 10, 2026, 2:15 PM EST. Pinterest (PINS) trades at $27.14, down 11.5% over the past year, with a 2% weekly gain. The stock carries a valuation score of 6/6. A Discounted Cash Flow (DCF) model yields an intrinsic value of $51.71 per share, implying about a 47.5% undervaluation versus the price. The analysis uses last twelve months free cash flow near $1.13 billion, with forecasts through 2030 climbing to about $2.0 billion. The stock trades at a P/E of 9.23x, well below the industry average of roughly 17x. Investors weigh sentiment shifts in social-media advertising against steady cash-flow growth. Note: DCF inputs are assumptions; treat valuation alongside other metrics.

American Tower (AMT) undervalued after price weakness, DCF suggests 37% gap

January 10, 2026, 2:14 PM EST. American Tower (AMT) shares closed at $168.51, down 3.6% over the past week and 6.5% over 30 days. A fresh valuation review places the stock at about a 37.3% discount to a DCF-derived intrinsic value of roughly $268.64 per share, suggesting the shares are undervalued. The model also notes AMT earns a P/E ratio of 26.8x, above the Specialized REITs sector average. The analysis points to strong demand for listed tower REITs that support mobile and data connectivity, while highlighting interest-rate sensitivity as a risk factor. The company scores 6/6 on valuation checks, reinforcing the case for tracking AMT in a diversified portfolio.

OpenAI weighs $830B-$1T IPO as Altman says public life could be really annoying

January 10, 2026, 2:13 PM EST. OpenAI is weighing a potential IPO that could value the company at $830 billion to $1 trillion, people familiar with the matter said. CEO Sam Altman told The Big Technology Podcast he's not excited about being a public-company chief executive and that taking OpenAI public would bring trade-offs he finds unattractive, even as a listing could unlock capital. OpenAI has not filed for an IPO; insiders have projected a 2027 listing with a possible filing in late 2026, and internal estimates have approached $1 trillion, Reuters previously reported. Altman said the company would need substantial capital to scale, even as it remains privately held under the governance of the nonprofit OpenAI Foundation, which retains control and holds an equity stake around $130 billion. Microsoft's stake was reduced to about 27% after a 2015 recapitalization. Google's Gemini 3 competition adds pressure.

HUZ: AI-Generated Signals Sustain Strong Ratings for Global X Silver ETF

January 10, 2026, 1:44 PM EST. As of Jan 10, 2026, AI-generated signals for the Global X Silver ETF (HUZ:CA) show a buy near 27.64, with a stop at 27.50. No short positions are offered at this time. The data highlight an available timestamp check and point to updated AI-generated signals for HUZ:CA. Ratings across Near, Mid, and Long horizons are Strong. The plan provides a single Buy entry and no target price. The signals aim to guide entry discipline rather than define exits. Investors should consider liquidity, fees, and market context when acting on these signals. The report notes a chart for Global X Silver ETF (ticker HUZ:CA).

Sebi Nears Approval for NSE IPO This Month

January 10, 2026, 1:42 PM EST.Sebi is nearing approval for the NSE IPO (initial public offering) this month, ending a delay that began in 2016. Chairman Tuhin Kanta Pandey said the regulator is in advanced stages and a no-objection certificate could be issued soon. The NSE's listing has faced regulatory and legal hurdles, now addressed through corrective steps and settlements. The issue would bolster the exchange's capital base and could lift market confidence in India's equity landscape. Analysts see a potential rebound in IPO activity if the process completes. Pandey's remarks underscore progress, though formal clearance remains pending. A successful IPO would mark a milestone for Indian markets and signal regulatory reforms aimed at improving transparency and investor access.

MSCI Narrative Shifts as Growth Cools and Valuation Narrows

January 10, 2026, 1:41 PM EST. MSCI's fair value estimate was trimmed only marginally, from about $657.56 to $657.40, with small cuts to revenue growth assumptions and the discount rate. Analysts cite rising confidence in recurring revenue and client retention, while trimming expectations for Sustainability product growth. Bullish Takeaways: Clear Street sees MSCI as a high-quality name with sticky revenue, strong margins and retention that justify a premium multiple, even with a cautious rating. Bearish Takeaways: Clear Street starts with a Hold and a $555 target, arguing much of the quality is already in the price and Sustainability growth is slowing. Separately, the NYSE will host U.S. options on several MSCI indexes in 2026; MSCI launched new indices and issued senior unsecured notes to fund activities, including a buyback plan up to $3B.

Klaviyo (KVYO) growth priced in as DCF flags overvaluation

January 10, 2026, 1:28 PM EST. Klaviyo shares trade around $28.58 after a 27.5% slide in the past year. The move comes as investors reassess its growth story amid tighter digital marketing budgets and a broader shift toward customer data platforms. The stock holds a valuation score of 2 out of 6, with two checks indicating undervaluation. A two-stage DCF model yields an intrinsic value of about $11.63 a share, suggesting the stock is overvalued by roughly 145.8% relative to the current price. A price-to-sales lens shows a top-line focus, but the valuation remains top-heavy as growth expectations weigh on multiples. More detail on the valuation approach is available in the full company report.

Analysts shift targets as LSEG fair value stays at £122.84

January 10, 2026, 1:09 PM EST. London Stock Exchange Group's Fair value estimate stays at £122.84 per share as analysts adjust assumptions. Move blends upbeat and cautious views into a target. JPMorgan keeps an Overweight rating and lifts its target to 13,300 GBp from 12,800 GBp, signaling confidence in execution and growth. RBC Capital maintains an Outperform rating and raises its target to 13,400 GBp from 13,200 GBp, noting progress justifies higher value. Deutsche Bank cuts its target to 1,190 GBp from 11,500 GBp while keeping a Buy rating, a cautious read on upside, valuation, and near-term risks. Separately, LSEG unveiled a Nasdaq partnership to distribute private markets data via LSEG Workspace, part of building private market infrastructure after launching the UK's first Private Securities Market in 2025. Note: fair value is an estimate of worth; price target is what analysts expect the stock to reach.

Aristocrat expands buyback to A$1.50 billion, weighing capital returns against NeoGames integration

January 10, 2026, 12:42 PM EST. Aristocrat Leisure boosted its on-market buyback to A$1.50 billion and extended it to 5 March 2027. Management presents the move as part of a balanced capital strategy alongside the NeoGames integration and the Aristocrat Interactive rollout. The near-term catalyst remains execution and cost discipline as NeoGames costs bite. A larger buyback reduces share count, but its impact depends on how quickly the digital operations scale and whether capital stays flexible for M&A and internal projects. The narrative rests on Aristocrat's growth plan, with forecasts for roughly A$7.3 billion revenue and A$2.0 billion earnings by 2028, implying mid-single-digit growth and meaningful earnings uplift. Fair value estimates vary, but about A$72.81 signals roughly 27% upside from current levels; investors will weigh valuation against execution risk.

Exact Sciences (EXAS) Valuation in Focus After 3-Month Rally

January 10, 2026, 12:41 PM EST. Exact Sciences Corp. (EXAS) has surged, up about 75% in 90 days and 81% over 12 months, spotlighting its cancer-testing franchise. The stock trades near $102 versus a narrative fair value of about $103.67, signaling modest upside. A multi-year cost-cutting push targets about $150 million in annual savings by 2026 via automation and AI-enabled lab efficiencies, aiming to lift EBITDA (earnings before interest, taxes, depreciation and amortization) and margins as scale grows. Licensing Freenome's blood-based colorectal screening tech could broaden optionality and accelerate time-to-market, leveraging existing sales channels. Risks include heavy R&D and deal spend and ongoing reliance on Cologuard. With a negative five-year TSR, valuation depends on execution and whether the market prices in future growth or views the risk differently.

LGI Homes valuation signals fair value of $75.67 as shares sit at $53.28

January 10, 2026, 12:40 PM EST. Last close for LGI Homes (LGIH) was $53.28 as a widely followed narrative argues for a higher fair value. A Simply Wall St analysis sets that fair value at $75.67, implying a 29.6% discount to the current price. The thesis relies on a durable demand tailwind from Millennials and Gen Z entering peak homebuying years, supporting long-run unit growth and revenue expansion as affordability improves. Analysts expect faster top-line growth but forecast a step down in margins and a different earnings multiple several years out (the price investors pay for a company's earnings). Key risk: ongoing affordability pressures and higher cancellation rates could derail the re-rating. The piece clarifies it is not financial advice and provides standard disclosures.

Crinetics Valuation Gap Widens After $350M Equity Raise, PALSONIFY Launch and Positive Atumelnant Data

January 10, 2026, 12:39 PM EST. Crinetics Pharmaceuticals CRNX is back in focus after a US$350.139 million follow-on equity offering, a PALSONIFY launch that generated more than US$5 million in revenue, and a positive Phase 2 readout for atumelnant in congenital adrenal hyperplasia. The stock has risen about 18.5% in the last 90 days and a five-year total return near 275%. At US$53.25, the shares trade at a P/B of 4.7x, below the peer average of 8.4x but above the broader US pharma group at 2.6x. Simply Wall St flags the discount to peers; a SWS DCF model puts a fair value near US$530.47, implying roughly a 90% intrinsic value gap. The company remains unprofitable with clinical, regulatory and commercialization risks that could spoil the rally; investors should weigh whether this represents mispricing or a catalysts-led setup.

Want $1 Million in Retirement? 11 Simple Index Funds to Buy and Hold for Decades

January 10, 2026, 12:09 PM EST. A retirement plan hinges on disciplined saving and broad stock exposure. The piece models growth using an 8% annual return, showing how recurring contributions could reach $1 million over multiple decades, and notes that higher savings or returns could accelerate the timeline. It also warns that the 4% withdrawal rule may understate needs in longer retirements due to inflation, especially if retirement is 25 years away. The article lists 11 index funds in ETF form, nine with broad buy-and-hold appeal for five-plus years, including VOO, VTI, VT, and PFF. It emphasizes low fees, diversification, and starting early to harness compounding, and it compares planned savings to Social Security's average benefit of about $2,013 per month.

History signals potential pullback in 2026 as S&P 500 valuations rise

January 10, 2026, 12:08 PM EST. Two indicators suggest the market may be stretched. The S&P 500 forward price-to-earnings (P/E) multiple sits around 22, above five- and ten-year norms and near levels seen in the dot-com era and the COVID-19 peak. A separate gauge, the Shiller CAPE ratio, sits near 39, the highest since 2000, a level often followed by weaker returns. While strong earnings can support prices, a correction would reflect a mismatch between expectations and actual results. Analysts caution that AI, energy, and infrastructure tailwinds help explain recent gains, but valuations remain a risk if earnings fail to meet lofty expectations. Investors may need patience as the market digests evolving earnings visibility and policy signals.

Mercedes-Benz Group undervalued on DCF valuation with €69.63 intrinsic

January 10, 2026, 11:53 AM EST. Mercedes-Benz Group trades around €60.37 after a 2.5% weekly drop and a 0.6% monthly dip, though it has risen 19.2% in 12 months and 78.4% over five years. A valuation check by Simply Wall St gives a 4 of 6, while a two-stage Free Cash Flow to Equity DCF model yields an intrinsic value of €69.63 per share, implying the stock is about 13.3% undervalued versus the current price. The model uses €13.0 billion trailing free cash flow and projects €6.2 billion by 2030. On a traditional metric, the stock trades around a P/E 9. The analysis notes broader questions about how large automakers are repositioning in a shifting market and how investors re-rate established brands. Investors are watching whether the price softness hides upside vs peers.

WESPAC Increases Stake in GRID ETF, Signaling Confidence in Smart Grid Infrastructure

January 10, 2026, 11:52 AM EST. WESPAC Advisors SoCal, LLC boosted its stake in the First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (GRID) by 32,351 shares, a roughly $4.96 million addition. The quarter-end GRID position value rose by about $4.99 million, reflecting both purchases and price moves. The purchase lifts GRID to about 1.62% of the fund's 13F reportable AUM. After the trade, the fund's top holdings included SMH, GOOGL, AVGO, AAPL and MSFT, among others. As of January 6, 2026, GRID traded at $157.42, up 30.1% year over year and ahead of the S&P 500 by roughly 14.7 percentage points. The ETF has AUM about $5.26 billion, expense ratio 0.56%, and targets the NASDAQ Clean Edge Smart Grid Infrastructure Index, offering a concentrated, non-diversified exposure.

RBC lifts Tidewater Renewables target to C$6; fair value unchanged at C$5

January 10, 2026, 11:42 AM EST. RBC Capital boosted its price target on Tidewater Renewables (TSX: LCFS) to C$6 from C$5.50, while leaving a Sector Perform rating intact. The upgrade signals raised confidence in ongoing project execution, even as management's core valuation anchor remains Fair Value at C$5.00 per share. The move does not alter the valuation framework; the discount rate nudged slightly lower from 7.06% to 7.03%. Separately, Tidewater completed a planned seven-day outage at the HDRD Complex in Prince George to reinstall a rebuilt component after an Oct. 2025 outage; utilization has moved back toward the full capacity of approximately 3,000 bbl/d from around 2,250 bbl/d during the interim period. Investors are watching how these developments influence the broader narrative and target revisions.

NCR Atleos (NATL) valuation after momentum; fair value $44.67 implies 8.8% undervaluation

January 10, 2026, 11:41 AM EST.NCR Atleos (NATL) has drawn fresh attention after a rally to $40.72, with a 7-day return of 9.37% and a 1-year total return of 27.29%. Analysts point to a high recurring revenue mix (70%+ in Q2), AI-driven service optimization and a growing backlog supporting margin expansion and free cash flow. A narrative fair value of $44.67 implies an 8.8% undervaluation, yet the stock trades at a 23x P/E, richer than the 14.3x Diversified Financial average and above the company's own 20x fair ratio. With annual revenue of $4,322.0m and net income of $131.0m, the case hinges on sustaining digital/fintech momentum against ATM-centric competition and cash relevance. Investors may want to stress-test assumptions and watch buybacks and EPS growth.

ETM's Nasdaq ambition reshapes Western critical minerals role

January 10, 2026, 11:40 AM EST. Energy Transition Minerals has appointed Ballard Partners as its US public policy adviser and Cohen & Company Capital Markets as exclusive US financial adviser to push a planned Nasdaq listing and advance the Kvanefjeld rare-earth project in Greenland. The moves aim to tap US capital markets and align with Western efforts to secure critical mineral supply chains. If successful, the listing could lift the company's profile with US policymakers and finance early-stage development, even as ETM reports negligible revenue, ongoing losses and elevated valuation. Risks include equity dilution, a relatively inexperienced board, and regulatory uncertainty around uranium. A valuation report cited by market observers suggests the stock may be overvalued relative to fundamentals, with three fair-value estimates spanning from near zero to about A$0.039. Investors should weigh multiple perspectives.

Planet Labs rally widens valuation gap despite share surge

January 10, 2026, 11:39 AM EST. Planet Labs PBC closed at $22.71 after an 11% weekly gain and a near 76% jump over the past month, even as valuation checks flag risk. The company's valuation score sits at 0/6, with a DCF model delivering an intrinsic value near $2.16 per share, implying the stock is overvalued by about 949%. The analysis uses a 2-stage Free Cash Flow to Equity approach; last twelve months' FCF was $46.83 million, with projections from $23.62 million in 2026 to $36.16 million in 2035. On the price-to-sales metric, the stock trades at 25.22x sales, well above historical norms. Investors are weighing government and commercial imaging contracts against the hefty valuation, and the piece notes several red flags in the full valuation breakdown.

Amerigo Resources Under Copper-Fueled Hype Amid Electrification Debate

January 10, 2026, 11:38 AM EST.Amerigo Resources, a copper-focused miner with Chilean operations, has drawn fresh attention as markets link electrification themes to commodity demand. Resource investor Rick Rule highlighted Amerigo among his preferred natural-resource names, lifting sentiment even as fundamentals remain unchanged. Analysts say the move reflects macro debates-currency debasement, geopolitical nationalism, and underinvestment in future production-rather than a shift in strategy. Near-term catalysts stay operational: meet 2025 copper and molybdenum guidance, maintain plant availability, and support dividends and buybacks. Key risks include copper price volatility and Chilean operational reliability, which could temper upside. Valuation remains debated, underscoring the need to balance upside narratives with execution risk.

Tecan Group: DCF signals undervaluation as shares trade at CHF151

January 10, 2026, 11:37 AM EST. Tecan Group TECN trades at CHF151.00, a level that masks a longer stretch of weaker returns. In the last year, the stock underperformed peers, though recent days show a rebound amid shifting sentiment. A 2-stage Free Cash Flow to Equity model values the shares at CHF288.74, implying a 47.7% discount to the current price and suggesting the stock is undervalued on cash-flow fundamentals. The company carries a valuation score of 4 out of 6 and a P/E of 30.38x, versus the Life Sciences sector. Investors should weigh diversification of growth prospects and risk when assessing upside beyond today's level. The numbers frame a cautious, momentum-sensitive market view rather than a unilateral call.

MP Materials slumps in December, eyes 2026 rebound on DoD deal and Venezuela supply hopes

January 10, 2026, 11:06 AM EST. MP Materials shares have swung on geopolitics and deal news. The stock fell 18.5% in December as China signaled delays to rare-earth export restrictions, easing immediate pressure for a U.S. supply push. Yet the year so far has been strong, with a roughly 23.7% rise in 2026 on the back of a transformative DoD partnership and a $500 million deal with Apple. Traders often treat MP Materials as a proxy for geopolitical risk around rare-earths and magnets. Risks include a U.S. government stake, future regulatory hurdles, execution risk on the 10X Facility and funding needs. A Venezuela tilt-potentially richer in Dy and Tb-could reshape supply lines for Mountain Pass and the Texas magnet plant, if relations improve.

Buffett backs S&P 500 ETFs VOO and RSP for long-term hold

January 10, 2026, 11:05 AM EST. Warren Buffett continues to advocate buying the S&P 500 index and holding it for the long run. The Oracle of Omaha, though stepping back from Berkshire Hathaway's day-to-day, remains a touchstone for many investors. He favors exposure via exchange-traded funds. Two widely cited options are Vanguard S&P 500 ETF (VOO) and Invesco S&P 500 Equal Weight ETF (RSP). The logic is simple: the S&P 500 tracks the broad U.S. economy through 500 large companies across sectors, and has a long history of expansion. The index is market-cap weighted, so the biggest firms carry more influence, for better or worse. RSP offers equal-weight exposure, reducing concentration in megacaps. Costs matter-VOO's expense ratio is around 0.03%, among the lowest in the space.

S&P 500 hits new record as US data boost optimism

January 10, 2026, 11:04 AM EST. The S&P 500 closed up 0.65% to a fresh record, with the Dow Jones and Nasdaq 100 rising as March futures gain. A resilient US labor market supported stocks after the unemployment rate fell to 4.4% and average hourly earnings rose 3.8% year over year, even as nonfarm payrolls expanded by 50,000 in December, below expectations. The University of Michigan January sentiment index rose, underscoring optimism about demand. Global risk appetite and earnings momentum helped lift equities, while hawkish remarks from a Federal Reserve official kept a lid on ultra-high bets. Housing data showed mixed signals, and investors await next week's data flow for clues on policy trajectory.

Haoxin Holdings jumps 31% in a month, but earnings still lag market

January 10, 2026, 10:33 AM EST. Haoxin Holdings Limited (NASDAQ:HXHX) has surged about 31% in the last month, but the stock remains lagging the market overall. Year-to-date, the shares are roughly flat after the bounce. The stock trades at about 2.2x P/E, well below the ~20x level many US peers command, a sign the market may require stronger earnings. Recent trends have weakened: EPS declined 36% over three years, with last year's bottom line roughly the same as the year before. With the market pricing in roughly 16% earnings growth next year, Haoxin's P/E may reflect limited upside unless profits improve. No analyst estimates are available. Investors should be cautious: a sustained earnings dip could compress the multiple further.

BCE vs Telus: Which TSX Dividend Stock Is a Better Buy in 2026?

January 10, 2026, 10:18 AM EST. Canadian telecoms BCE and Telus are reshaping capital returns as they rebuild balance sheets. BCE cut its dividend 56% to $1.75 a share; Telus paused dividend growth. By January 2026, both sit about 50% off their all-time highs, with Telus yielding above 9% and BCE about 5.4%. BCE's plan targets roughly 15% annual FCF growth through 2028, about $22 billion of cumulative FCF before capex, and $5 billion in dividends, while reducing net debt leverage to 3x by 2030. Telus targets >10% annual FCF growth to 2028, with $2.15B in 2025 and $2.4B in 2026, and will shrink the DRIP (dividend reinvestment program) to zero by 2028. Valuation shows BCE at ~8.9x forward FCF (vs 10-year avg 14x) and Telus at ~12x (vs 21x). Consensus implies ~19% (BCE) and ~30% (Telus) 12-month returns. For income-focused investors, BCE's path may appeal.

Synergy CHC Insider Buying Outpaces Selling; 40% Insider Ownership Highlights Alignment

January 10, 2026, 10:05 AM EST.Insiders at Synergy CHC Corp. (NASDAQ:SNYR) were net buyers over the past 12 months, buying more stock than they sold. The largest single purchase came from Jack Ross, who bought about 83,400 shares for roughly US$82,000 at an average price of about US$2.90. By contrast, the current share price trades around US$1.81. The biggest individual buy was at US$6.18 per share, signaling confidence even at a higher price. Insider ownership stands at about 40%, valued at roughly US$8.3 million, a level that can align incentives with other shareholders. There have been no insider transactions in the last three months. While insider activity isn't a guarantee of future results, it's one data point investors monitor. Our analysis flags six warning signs for Synergy CHC, three of which are significant.

IQVIA Debt Load Seen Manageable, But Dilution Risk Remains

January 10, 2026, 10:04 AM EST. As of September 2025, IQVIA Holdings carried about $15.0 billion of debt and $1.97 billion of cash, yielding net debt of roughly $13.0 billion. Off-balance liabilities total about $17.2 billion versus cash and short-term receivables, but the company trades around a $41.4 billion market cap, suggesting capacity to raise funds if needed. The firm's debt-to-EBITDA ratio sits at 4.5x, while EBIT covers interest expense about 3.4x. (EBITDA = earnings before interest, taxes, depreciation and amortization; EBIT = earnings before interest and taxes.) The numbers imply a sizable but manageable leverage profile rather than an imminent default risk. Still, any capital-raising to bolster the balance sheet could dilute existing shareholders.

Compass (COMP) valuation check after momentum

January 10, 2026, 10:03 AM EST.Compass (COMP) has drawn fresh attention after sharp momentum, as investors reassess the real estate brokerage platform's fundamentals. The stock trades near US$12.84 after a 4.73% one-day gain and a 22.29% seven-day rise, with a 90-day return of 82.39%. Over 1 year, TSHR is about 140%; over 3 years, roughly 2.6x. The valuation split is clear: consensus fair value about US$10.67 (implied discount ~13%), while a DCF fair value sits around US$14.72, implying upside if profitability improves. A key support includes estimated cost synergies around US$225 million, about 8% of the operating expense base, enhancing margins and free cash flow. Risks: regulatory scrutiny of commissions and potential disruption from digital or direct models. The narrative remains: can Compass sustain margins and growth to justify higher multiples?

Wallbox Near Breakeven; Analysts See 2028 Profit After 2027 Loss

January 10, 2026, 10:02 AM EST. Wallbox N.V., a technology firm that designs and sells charging solutions for residential, commercial, and public use, posted a €149 million loss for the latest year, with a trailing twelve-month loss of €103 million. The $47 million market-cap company has narrowed losses as it nears breakeven (i.e., no net loss or profit). Analysts from two American firms see a loss in 2027 followed by a €21 million profit in 2028, placing breakeven roughly two years from today. To reach that timing, the implied compound annual growth rate is about 64%, a high pace that depends on ongoing investment. The stock carries a debt-to-equity ratio above 2x, well above the rule-of-thumb 40% ceiling, signaling higher capital-management risk. This is a high-level view; deeper fundamentals require more analysis.

ETF Playbook 2026: Real Estate (VNQ) and Small-Cap (VTWO) as the Backbone

January 10, 2026, 9:50 AM EST. An experienced investor shifts from stock picking to ETFs to build a durable backbone. The author plans 2026 buy decisions around Vanguard Real Estate ETF (VNQ) as rates trend lower, arguing REITs benefit from cheaper borrowing and money rotating into higher-yielding assets. VNQ's 0.13% expense ratio underpins income-focused exposure. The piece also flags small-cap value: valuations in the Russell 2000 line up with the potential for outperformance as megacaps and AI momentum run hot elsewhere. The author points to the Vanguard Russell 2000 ETF (VTWO) as the biggest 2025 investment and intends to keep accumulating shares. The broader message: a disciplined mix of real estate exposure and small-cap exposure can weather rate cycles and compound over time.

Travelers Companies posts 118% five-year TSR as EPS growth outpaces price gains

January 10, 2026, 9:49 AM EST. Investors in Travelers Companies (NYSE: TRV) have enjoyed a strong five-year return, with a 118% TSR driven largely by dividends reinvestment, far above the 97% rise in the share price noted in the period. Over the same horizon, EPS grew about 24% per year, outpacing the roughly 15% annual gain in the stock price. The market appears cautious, with a P/E around 10.8, even as near-term momentum brightens. In the last year, TSR rose 23% including dividends, suggesting improved performance despite a slower longer-term pace. The analysis underscores that TSR can exceed price return when dividends are reinvested, leaving questions about whether fundamentals can sustain the trend.

Saint-Gobain valuation after 2.4% daily gain; fair value near €104

January 10, 2026, 9:47 AM EST. Saint-Gobain rose 2.4% to €84.60 in the latest session, after softer weekly moves. Over 7 days the stock +2.8%, 90 days +3.4%, but 3 months and year-to-date returns are negative. The 1-year TSR stands at 2.9%, while 5-year TSR tops 125.1%, underscoring longer-term gains despite near-term pressure. Analysts price target sits around €103, leaving an intrinsic-value gap near 25%, with fair value pegged at about €104.25, implying the shares look undervalued on a discounted-cash-flow path. The bull case rests on ongoing cost optimization via digitalization, automation, procurement, supporting margins even if volumes stagnate. Risks include high fixed costs in a downturn and volatile raw materials and energy costs that could erode pricing power. Investors may want to widen their watchlists and test scenarios.

Kura Sushi USA (KRUS) Has Cash Runway to Fund Growth; Burn Rate Matters

January 10, 2026, 9:38 AM EST. Kura Sushi USA's cash position and burn trajectory are under close watch. As of November 2025, the company had cash of US$51 million and no debt, with trailing twelve-month cash burn of US$29 million, implying about a 21-month cash runway. The burn declined 3.0% in the last year while revenue rose 16%, indicating some operating discipline and improving momentum. The key question is whether the company can sustain growth with limited external funding. Publicly listed firms can raise new funds via issuing equity or taking on debt; KRUS's burn equates to roughly 3.5% of its approximate US$838 million market capitalization, suggesting modest headroom to fund operations without immediate dilution or leverage. Investors should weigh growth prospects against the cash runway and potential financing needs.

GGRO AI signals, trading plans outlined for iShares ESG Growth ETF (GGRO:CA)

January 10, 2026, 9:37 AM EST. Jan. 10, 2026, 09:05 ET. A market note by Robert S. with editor Derek Curry lays out trading plans around the iShares ESG Growth ETF Portfolio, ticker GGRO:CA. The plan shows a long entry near 67.33 with a target of 69.39 and a stop at 66.99, alongside a short setup near 69.39 with a target of 67.33 and a stop at 69.74. The note references AI-Generated Signals for GGRO:CA and directs readers to updated signals. For GGRO:CA ratings on January 10, near-term is Strong, mid-term Neutral, and long-term Strong. The content underscores timestamped AI guidance and a split view for traders weighing long or short positions.

Carvana valuations under scrutiny after 140% year-over-year rally

January 10, 2026, 9:36 AM EST. Carvana (CVNA) has surged about 140% over the past year, trading around $463 as investors weigh its core value. The stock rose 15.7% last week but is flat to slightly down over the past month. A company-valuation check scores Carvana 0/6. The analysis uses a Discounted Cash Flow (DCF) model to estimate intrinsic value; in this case a two-stage Free Cash Flow to Equity forecast yields about $403.68 per share, implying the share price is roughly 14.7% above intrinsic value. The article also notes a sharp P/E ratio of about 104x, signaling elevated expectations and risk. In short, the current price sits at odds with the modeled value, suggesting potential overvaluation rather than a bargain.

Peabody Energy (BTU) Valuation Check After Strong Multi-Year Share Price Rally

January 10, 2026, 9:35 AM EST. Peabody Energy Corp (BTU) has caught investors' attention as the stock trades near $33.80 after a year of double-digit gains and a five-year total return of about 7x. The note cites momentum, with a 1-month return of 19.82% and a 7-day gain of 10.17%, versus an analyst target near $34.80. The analysis puts a near-term fair value of $34.80 and an intrinsic value of about $86.10, signaling a potential valuation gap. It cites cost control, operational efficiency and asset optimization driving lower costs per ton and supporting EBITDA, with dividends and buybacks helping EPS growth. Risks include renewables demand risk and tighter environmental rules that could raise long-run costs. On a P/S around 1x, the stock looks cheap versus peers, but a fair multiple might be ~0.7x.

Centene valuation signals undervalued after price rebound

January 10, 2026, 9:34 AM EST.Centene's stock closed at $46.61 after an 11.6% weekly gain and 20.5% in the month, yet remains down 24.6% in 12 months and 39.5% over three years. In a DCF view, Centene's estimated intrinsic value is $213.18 per share, implying the stock trades at a 78.1% discount to fair value. That supports a view of undervalued shares. The analysis notes a P/S ratio of 0.14x versus the Healthcare sector average of 1.26x. The latest twelve-month Free Cash Flow is about $3.24 billion, with 2030 projections around $4.04 billion. Centene earns a 5/6 in valuation checks, underscoring mixed signals. Investors should consider these signals in a broader framework while watching sentiment shifts.

Allstate (ALL) appears undervalued as Excess Returns model pegs intrinsic value at $575 vs $212 share price

January 10, 2026, 9:33 AM EST. Allstate closed at $212.21, with weekly gains of 4.1%, a 5.5% monthly rise, and a 19.6% year-to-date advance. Five-year and three-year climbs run 121.4% and 63.8%, framing a debate on valuation. The analysis ranks Allstate with a 5/6 valuation score for apparent undervaluation. The Excess Returns model pegs an intrinsic value of about $575.74 a share, vs. $212.21 now, implying the stock is about 63.1% undervalued. Inputs include a Book Value of $97.34, Stable Book Value of $133.76, Stable EPS of $25.64, and a cost of equity of $9.30. The piece also touches on the role of the P/E ratio in assessing earnings power and the influence of sector pricing and regulation on shares.

Elevra Lithium climbs 9.5% as lithium price rebound tests bull case

January 10, 2026, 9:32 AM EST. Lithium prices have rebounded after a three-year bear run, driven by battery energy storage demand and supply discipline. Elevra Lithium, a North America-focused producer, may benefit from scale and cost management as the market tightens. The near-term catalyst is FY2026 guidance for production and sales of 195,000 to 210,000 dmt, with higher prices potentially lifting margins if costs stay contained. But the stock faces dilution and execution risk: a recent A$109 million equity raise, and losses of A$294.29 million, alongside a changeful management team. Valuations vary widely, with Simply Wall St placing fair value estimates from A$0.01 to A$9.77. The rebound supports upside, but delivery remains crucial.

Microsoft Seen as Best Trillion-Dollar Buy for 2026, Wall Street Says

January 10, 2026, 9:18 AM EST. Wall Street analysts see a clear winner among trillion-dollar megacaps for 2026: Microsoft. The stock carries a median price target of $630 per share, about 33% upside, edging Nvidia and Broadcom. Nvidia's target sits near $250 and Broadcom around $460, roughly 32% upside. Yet Microsoft offers a more favorable risk-reward given its valuation and steadier growth. Analysts expect Nvidia revenue up around 50% and EPS up 60% this year; Broadcom shows a similar trajectory tied to AI accelerators. By contrast, Microsoft is projected to grow revenue about 16% this year with a similar EPS gain, with Azure driving monetization of AI investments. The cloud service's strength cushions risk versus chipmakers reliant on a few large customers.

Algoma Central: ROE in line with peers as stock climbs 13% in 3 months

January 10, 2026, 9:16 AM EST. Algoma Central Corp (TSX: ALC) has risen about 13% over the past three months as investors weigh its longer-term health. The trailing twelve-month ROE is 11% (CA$101 million in net income against CA$927 million of shareholders' equity) for the period to September 2025. That level sits near the industry average of 12% and aligns with a roughly 10% five-year net income growth. Relative to peers, the key question remains whether expected earnings growth is already priced in, with the P/E multiple used as a gauge. The payout framework shows a moderate three-year median payout ratio of 32%, implying room to reinvest profits. In short, ROE, the payout policy, and the growth trajectory shape the outlook for ALC.

Sebi chief says NSE IPO to get no-objection certificate by month-end

January 10, 2026, 9:05 AM EST. India's market regulator, Sebi, said it will issue a no-objection certificate for the NSE IPO soon, possibly before month-end, after years of regulatory and legal uncertainty tied to a dark fibre case that alleged preferential access to co-location servers. Sebi's action clears a major hurdle for the exchange, whose unlisted value exceeds that of listed rival BSE on market data. The decision comes as NSE holds a dominant share in cash equity and options. Separately, Sebi signaled limited traction for a T+0 settlement rollout despite its January 2023 shift to T+1 and a March 2024 optional phase; the regulator cited disruption and uncertain benefits. Sebi also plans to publish a framework for performance-linked expense ratios in mutual funds to boost fee transparency.

Playtika's ROCE declines as reinvestment grows; not a clear multi-bagger signal

January 10, 2026, 9:04 AM EST. Playtika Holding's ROCE is 14% for the trailing twelve months to September 2025, above the Entertainment industry average of 6.9%. Yet the longer trend looks weak: ROCE has dropped from about 40% over five years as capital employed rises while sales have stagnated in the past year. The company appears to be reinvesting for growth, but it may take time before earnings reflect these bets. It has reduced current liabilities to roughly 19% of total assets, easing some funding risks but potentially hindering near-term efficiency in generating ROCE. The stock is down about 87% over five years, highlighting investor skepticism about a multi-bagger outcome. The setup remains uncertain and investors should weigh the reinvestment narrative against the lack of earnings growth.

TE Connectivity's net debt around $4.63 billion; balance-sheet risk seen as manageable

January 10, 2026, 9:03 AM EST. TE Connectivity plc (NYSE: TEL) carries notable debt. As of September 2025, debt stood at about $5.89 billion, up from $4.30 billion a year earlier. With cash of roughly $1.26 billion, net debt is about $4.63 billion. Total liabilities run about $12.35 billion, while cash and near-term receivables total about $4.66 billion, leaving an approximate $7.69 billion gap to cover obligations in the near term. With a market capitalization near $68.1 billion, some readers will view the liabilities as manageable given scale, though risk remains if earnings fail to service the debt. Analysts assess liquidity using net debt/EBITDA and interest coverage to gauge debt relative to earnings, and advise monitoring the balance sheet going forward.

BlueLinx Holdings climbs 19% in a week as ROE lags peers; earnings trajectory under scrutiny

January 10, 2026, 9:02 AM EST. BlueLinx Holdings' stock jumped about 19% in the past week, even as its ROE sits at 2.3% for the last twelve months through September 2025. The figure, derived from $14 million in net profit on $623 million of equity, trails the sector average ROE of around 14%. The company has posted a five-year net income decline of about 29%, sharpening concerns about earnings growth. By contrast, the broader industry earnings rose about 13% over the same five-year period. Investors will decide whether the present price reflects the outlook for earnings growth. Our view: more evidence of improving profitability is needed to sustain gains.

Samsara stock slides 25% as elevated P/S ratio weighs on investors

January 10, 2026, 9:01 AM EST.Samsara Inc. shares tumbled 25% over the last month, erasing gains from earlier in the year and putting the stock on track for a rough 12 months. The drop follows a 23% decline over the past year. The stock trades at a price-to-sales ratio of 12.8x, or P/S-a valuation metric that compares a company's market value to its revenue. The figure remains well above many software peers, where P/S often sits under 5x, and sometimes below 2x. Samsara has posted stronger revenue growth recently-up 29% year over year and 157% over three years-helping justify the lofty multiple for some investors. Analysts forecast about 22% annual revenue growth over the next three years, versus roughly 32% for the broader software group. If growth decelerates, the high P/S may weigh on the stock.

One smart move for investors as 2026 market risks loom

January 10, 2026, 8:46 AM EST. Markets saw record growth in 2025, but optimism faces headwinds as a quarter of investors expect a downturn. The Buffett indicator, GDP-to-market cap, sits around 221%, well above the 200% level last seen before the 2021-22 bear market. Some experts say forecasting a crash is impossible; others warn valuations may be stretched. Regardless of timing, the article flags a single prudent move: ensure portfolios are built on quality stocks with sound fundamentals. Strong firms tend to weather economic stress, while weaker peers may falter. Price alone is insufficient to judge strength; hype can mask weakness. The guidance is to favor durable earnings, balance sheets, and cash flow, and to avoid chasing speculative rallies, staying focused on long-term discipline.

Exact Sciences (EXAS) undervalued after 81% one-year surge, DCF suggests

January 10, 2026, 8:44 AM EST. Exact Sciences trades near $102 a share after an 81% one-year gain. The stock shows a mixed 2024-25 profile, with modest recent momentum and a sharp rise over the past year driven by its cancer-screening portfolio. A Discounted Cash Flow (DCF) model puts fair value at about $147.50 per share, implying the stock is about 30.8% undervalued versus today. The latest twelve-month Free Cash Flow is about $222.4 million; under a two-stage FCF-to-Equity framework, 2030 cash flow is projected near $1.07 billion, with nearer years in the hundreds of millions. On multiples, the stock trades at a P/S of 6.29x, below the Biotech industry average. Ultimately, valuation hinges on cash flow execution, growth potential, and how the test portfolio fits broader healthcare trends.

Investors more bullish on NL Industries as stock soars this week despite earnings trend lower over five years

January 10, 2026, 8:38 AM EST.NL Industries (NYSE:NL) shares jumped more than 20% this week. Over five years, the price is up about 38%, trailing the market, but dividends push total returns ahead. The stock is down about 12% in the last year. Earnings per share (EPS) have fallen about 10% annually over the period, suggesting investors are weighing other metrics. Revenue growth has averaged 4.8% per year, a constructive sign for the top line. The five-year total shareholder return (TSR) runs around 98%, helped by dividends. In the near term, investors will monitor balance sheet strength and dividend appeal versus earnings momentum.

Array Digital Infrastructure: ROE Underperforms Industry as Stock Rises on Momentum

January 10, 2026, 8:37 AM EST. Array Digital Infrastructure (NYSE:AD) rose about 7.1% in the past three months. Its trailing ROE of 7.5% lags the industry average of 15% and comes as five-year net income has declined about 47%. The metrics hint at limited value creation for shareholders, given the high payout ratio and ongoing competition. Despite weaker profitability, the stock has gained on price momentum, raising questions about whether earnings growth is already priced in. By contrast, the industry posted earnings growth of roughly 37% over the same period. Investors should weigh whether earnings growth is reflected in the price and monitor profitability, retained earnings, and margin pressures as AD weighs future prospects.

Netflix (NFLX) eyed by Jefferies and Wolfe Research for upside and synergies

January 10, 2026, 8:36 AM EST. Netflix Inc. (NFLX) remains among favored communication services names among hedge funds. On December 17, James Heaney of Jefferies reiterated a Buy rating (analyst expects shares to rise) with a $134 target (the price the analyst expects the stock to reach), implying roughly 48% upside from current levels. Heaney said a bidding war for Warner Bros. Discovery (WBD) is unlikely, noting market pricing hasn't captured potential synergies. Peter Supino of Wolfe Research also reaffirmed a Buy rating (analyst expects shares to rise), trimming his target to $121 from $139, still about 33% upside. The stock is described as a subscription-based streamer with a broad library and personalized recommendations. Investors should weigh potential AI stock upside against risk as part of broader tech exposures.

Standex International: ROCE Rises to 9.5% as Five-Year Return Reaches 191%

January 10, 2026, 8:35 AM EST. Standex International (NYSE: SXI) shows improving returns on capital, with ROCE rising to 9.5% for the trailing twelve months through September 2025, though it remains below the Machinery industry average of about 11%. The gain comes as the base of capital employed grows, up 67% over five years, signaling reinvestment opportunities and a business model capable of compounding capital. The stock has delivered a 191% total return over the past five years. The analysis notes four warning signs, with one item causing particular concern. Investors may wish to examine Standex's capital allocation and growth prospects further; analysts' projections are available in the free report.

Richmond Mutual Bancorporation: Individual Investors Own 51%, Institutions 25%

January 10, 2026, 8:34 AM EST. According to Richmond Mutual Bancorporation's share registry as of Jan. 10, 2026, individual investors hold 51% of RMBI, making them the largest group. Institutions own 25%. The ESOP (Employee Stock Ownership Plan) is the largest single holder with about 11% of shares; second and third holdings are ~6.5% and ~6.0%. CEO Garry Kleer owns 1.8%. The top 25 holders control less than half of the stock, implying no single dominant owner. Analysts say there is little to no coverage, suggesting the stock may fly under the radar. Insiders include board members; governance remains subject to board oversight. Investors should also watch for risk when large holders trade in unison and review recent earnings trends.

PBF Energy Rally Triggers Valuation Questions After DCF Signals Overvaluation

January 10, 2026, 8:33 AM EST. PBF Energy trades around $32.77 after a sharp rally, up 14.9% over the last week and 22.4% in the past year. Longer horizons remain mixed: a negative three-year return but a sizable five-year gain. A valuation model gives a mid-range score of 3/6 on undervaluation. The DCF-based intrinsic value is about $2.52 per share, implying roughly 1,199% overvaluation versus the current price. Trailing free cash flow shows a loss of about $1.26 billion, with forecasts turning positive later in the decade (about $293 million in 2026 and $29 million in 2027). The analysis also cites the price-to-sales cross-check, noting multiples hinge on growth and risk. Overall, the rally may outpace the company's cash-flow fundamentals for now.

FormFactor (FORM) Valuation Gap After Momentum Rally

January 10, 2026, 8:32 AM EST.FormFactor has momentum after a sharp rally. 1-day +6.39%, 90-day +79.97%, with a latest price of $68.64. The 1-year TSR is 55.22%, and 3-year TSR around 1.7x. An analysis sets a fair value of $56.88, signaling a valuation gap as the stock trades above that level. The company's plan for new manufacturing in Farmers Branch, Texas, and vertical integration via organic substrate partnerships aims to lift production and margins amid growing AI and advanced packaging demand. If revenue forecasts and a margin rebuild hold, a premium multiple could persist. Risks include margin pressure from higher costs and tariffs, plus revenue swings tied to DRAM and HBM demand. This narrative is general in nature.

Teck Resources Valuation Check: Shares Trade Above Modelled Fair Value at CA$68.99

January 10, 2026, 8:31 AM EST. Teck Resources (TSX:TECK.B) closed at CA$68.99, with a valuation model showing the stock above its fair value. The calculated fair value sits at CA$62.94, up from about CA$62.39, reflecting stronger long-term assumptions and a higher forward multiple. The forward P/E is about 30.8x. Momentum is evident: 30-day returns around 14.35% and 90-day about 17.65%, with 1-year TSR at 14.70% and 5-year TSR near 196.39%. The verdict: the price largely reflects copper growth prospects, yielding an OVERVALUED call in the model. Risks include project delays that push copper expansion out and any weakness in copper or zinc prices that could hit revenue and margins. Readers can adjust inputs to rebuild the case; the piece also notes one key reward and one warning sign.

SCR-Sibelco shares jump, but valuation signals overvaluation after 16% rise

January 10, 2026, 8:30 AM EST. SCR-Sibelco's stock has surged about 16% in 30 days, trading near €5,450.00, but a valuation check scores the company 0/6. A DCF model using a two-stage Free Cash Flow to Equity framework points to an implied value of about €376.81 per share, well below the current price, suggesting the stock is overvalued by roughly 1,346%. The analysis notes a high P/E of 29.74x versus 22.12x for the metals and mining sector and 13.65x for peers. While the market has fixated on price action, fundamentals imply limited upside on cash flows given the base assumptions. Investors should distinguish short-term enthusiasm from long-term value and consider how growth, risk, and cash flow drivers may evolve beyond the numbers.

Albertsons declares $0.15 dividend; payout sustainability under scrutiny (ACI)

January 10, 2026, 8:29 AM EST. Albertsons Companies Inc. will pay a dividend of $0.15 a share on February 6, delivering a yield of about 3.6% based on share price. The payout appears to be covered by earnings, with most profits reinvested back into the business, and the company projects EPS to rise about 57.2% next year. If this pace continues, the payout ratio could reach roughly 26%, a level analysts deem potentially sustainable in near term. Over the last five years, the dividend has risen from $0.40 in 2021 to $0.60 most recently, a compound growth of about 8.4% per year, though the track record remains modest and uncertain. EPS has been flat over five years, tempering the case for a steady income stock. The report flags two warning signs for investors and notes the dividend may not be durable long term. Source: Simply Wall St.

Townsquare Media: Valuation Flags Amid Negative Earnings Outlook

January 10, 2026, 8:20 AM EST. Townsquare Media, NYSE:TSQ, has drawn attention after a price rally but remains shy of its yearly high. The stock trades at about 5.08x price-to-earnings ratio, far below the industry average of roughly 14.77x, signaling a cheaper relative valuation. Its price has been stable, underpinned by a low beta that suggests muted market swings. Yet the near-term outlook carries negative earnings growth, injecting risk into the thesis. As a small-cap with limited analyst coverage, mispricing can persist, though visibility may improve over time. Investors should weigh the cheap multiple against earnings uncertainty and consider diversification to manage risk while evaluating a potential TSQ allocation.

Is It Time to Add American States Water (AWR) to Your Watchlist?

January 10, 2026, 8:19 AM EST. Investors debating whether to buy into profitable stocks can overlook valuation, but American States Water (NYSE:AWR) is positioned differently. The company has posted steady growth in earnings and revenue, with EPS rising about 16% a year over the past three years and revenue up about 10% to $637 million in the latest period. The EBIT margins have been flat year over year, adding color to the quality of its growth. Insider ownership remains meaningful, with insiders holding roughly $26 million of shares (about 0.9% of the company), signaling alignment with shareholders. The discussion centers on whether these fundamentals justify a place on a watchlist as investors weigh profitability against broader market risk. An interactive chart touts future EPS estimates for planning and benchmarking.

Helios Technologies: DCF fair value near current price

January 10, 2026, 8:18 AM EST. Helios Technologies' fair value, calculated with a two-stage discounted cash flow, is US$71.84 per share. The current price of US$60.59 implies the stock trades near that estimate. An analyst target of US$65.20 sits about 9.2% below the fair value. The methodology projects the next decade of levered free cash flow (FCF) before discounting, then adds a terminal value to capture all subsequent cash flows. Present value of the first 10 years of cash flows is listed at roughly US$899 million, discounted at about 8.9%. The note assumes a two-stage growth path: higher early growth easing to a stable rate, and uses a 5-year average government bond yield (3.3%) for the terminal growth rate. Investors should note DCF models rely on inputs that can shift with estimates.

Onity Group's 14% five-year CAGR outpaced earnings growth, market performance mixed

January 10, 2026, 8:17 AM EST. Onity Group Inc. (NYSE: ONIT) posted a 90% five-year stock-price gain, ahead of the market's roughly 63% rise. Over the same period, EPS grew about 75% annually, surpassing the 14% annual rise in the share price and signaling improving profitability even as sentiment wavered. The company added roughly $50 million to its market cap in the past week. In the most recent period, the stock's one-year gains were 68%, while the five-year TSR runs about 14% per year. The piece notes two warning signs for ONIT and flags the stock as worth a closer look for investors seeking value and yield opportunities.

IAC: Valuation Hurdles but Upside on $45 Target, Jefferies Says

January 10, 2026, 8:16 AM EST. InterActiveCorp (IAC) faces valuation concerns despite resilient fundamentals. Oppenheimer's Jason Helfstein issued a Hold on IAC, citing limited growth from the sum-of-parts discount, though the $45 target implies about 17% upside. Jefferies' Brent Thill lifted his price target to $45 and kept a Buy rating, noting the firm's 2026 Internet Playbook cautions on AI disintermediation and margin pressure as Internet stocks navigate headwinds. Thill argues for selectivity among Internet names even as he remains positive on IAC's core fundamentals. IAC is a media and internet holding company with brands such as FOOD & WINE, Verywell, BYRDEI, Better Homes & Gardens, and Investopedia. The note suggests some AI stocks offer greater upside with potentially less downside amid onshoring/tariff dynamics. Source: Insider Monkey.

CoreWeave Stock Pulls Back After AI Rally; Nvidia Deal Provides Cushion

January 10, 2026, 8:15 AM EST. CoreWeave's stock has tumbled more than 50% from its 52-week high after a surging AI rally that carried the neocloud specialist from a March listing near $40 to a June peak around $187. The pullback comes as skepticism grows over the company's ability to sustain rapid growth. CoreWeave operates in neoclouds-AI-optimized data centers born from a crypto-mining pivot-and counts OpenAI, Meta, and Microsoft among its customers. Third-quarter revenue rose 134% year over year to $1.4 billion, but the business burned cash, posting a loss of $110.1 million as it ramps up capex. Long-term risk is tied to debt load above $14 billion. A new U.S. government sales unit and a $6.3 billion Nvidia deal provide cushion, yet investors remain focused on whether growth can outpace costs.

L3Harris among the most overbought after Trump calls for expanded defense budget

January 10, 2026, 8:14 AM EST. CNBC Pro's stock screener shows L3Harris Technologies among this week's overbought names with a 14-day RSI of 78.2 after roughly a 10% gain and a 52-week high on Friday. The move followed a Truth Social post by President Donald Trump calling for a $1.5 trillion defense budget in 2027; the stock is up about 14% year-to-date, with analysts' targets implying limited upside. Other overbought names include Ulta Beauty, Target, Centene, and United Parcel Service. On the flip side, oversold stocks include Apple (RSI 22.8), Paramount Skydance (RSI 29.8), and Campbell's. Alphabet briefly surpassed Apple in market cap for the first time since 2019; Apple is down 4.6% year-to-date.

Okta stock undervalued on DCF despite mixed signals; shares at $92

January 10, 2026, 8:05 AM EST. Okta's shares closed at $92.23, with a 10.3% weekly rise and a mixed longer-term path. The stock shows a valuation score of 2/6. A Discounted Cash Flow (DCF) model yields an intrinsic value of about $121.84 per share, implying a roughly 24% discount to the current price and an undervalued signal on this metric. Trailing free cash flow runs about $888.3 million; projections to 2030 reach about $1,312.6 million in present value terms. Headlines around identity and access management frame the risk-reward, underscoring growth potential versus security exposure. The P/E angle depends on growth and risk, leaving Okta with a mixed valuation picture.

Valmont Industries shares rise as ROE signals steady profitability but growth lags peers

January 10, 2026, 8:04 AM EST. Valmont Industries' stock has risen 9.1% over three months as investors weigh fundamentals against price action. The trailing twelve-month ROE stands at 16% (US$263 million profit vs US$1.7 billion in shareholders' equity), in line with, but just under, the industry average of 17%. ROE measures how efficiently a company turns shareholder capital into profit. By contrast, Valmont's five-year earnings growth trails the sector, while profit retention remains high: a three-year median payout ratio of 21% implies a 79% retention for reinvestment. The company has paid dividends for at least ten years, signaling commitment to shareholder returns. The question for investors is whether the current valuation already reflects these dynamics given slower growth relative to peers.

RBC Names Core & Main Preferred Pick; CNM Rises On Sector Backdrop

January 10, 2026, 8:03 AM EST. RBC Capital Markets named Core & Main as a preferred pick in a tougher sector backdrop. CNM shares rose above their 200-day moving average and benefited from positive earnings estimate revisions. The reaffirmation of CNM's full-year 2025 net sales guidance of $7.6-$7.7 billion underpins management confidence despite sector headwinds. Near-term catalysts hinge on execution toward modest growth, while investors monitor interest expense and construction activity trends. Risks include higher debt and exposure to a potential construction slowdown. The company projects revenue of about $8.7 billion and earnings of $645.7 million by 2028, implying roughly 4.4% annual revenue growth and a mid-teens earnings uplift. Fair value estimates vary, suggesting multiple viewpoints.

Insider Fred Cohen buys 303% more Intellia Therapeutics shares; $1.4 million stake

January 10, 2026, 8:02 AM EST.Intellia Therapeutics Inc. (NASDAQ: NTLA) said insider Fred Cohen bought US$1.4 million worth of stock at US$9.35, lifting his holding by about 303%. The purchase, around the current price of about US$10.38, marks the biggest insider buy at NTLA in the past year and signals confidence from an insider amid the company's ongoing losses. Over the past year, insiders bought US$2.4 million for 250,000 shares and sold US$974,000 from 99,980 shares, leaving insiders with net ownership of 1.7%-about US$20 million. The report notes insider alignment with shareholders, though investors should weigh the risks as the business tests profitability. Overall, this is a credibility signal, but not a guarantee of performance.

Cato's P/S Valuation Under Scrutiny Amid Revenue Decline

January 10, 2026, 8:01 AM EST. The Cato Corporation trades at a P/S of about 0.1x versus a US specialty-retail median near 0.5x, a gap that invites scrutiny. Revenue has declined over the past year, down about 1%, and has fallen 13% over three years, contrasting with an industry expected growth of roughly 8.1% in the next 12 months. The stock's P/S sits on par with peers despite the weak top line, raising questions about whether the valuation reflects downside risk. The absence of analyst forecasts limits near-term guidance, while investors seem to bet on a turnaround that may not materialize if revenue momentum does not improve. In short, the current growth trajectory and valuation imply potential for disappointment unless conditions change.

Xeris Biopharma Holdings (XERS) price rally under scrutiny after upbeat updates

January 10, 2026, 8:00 AM EST. Xeris Biopharma Holdings (XERS) closed near $7.93, up 7.9% last week, 14.3% over the past month and 133.2% in the last year. The stock's three-year run tops fivefold. Product updates, financing moves and partnerships have sharpened the focus on risk versus reward. On the valuation checklist, Xeris scores 3 out of 6 for being undervalued. A two-stage DCF model using cash flow to equity yields an intrinsic value near $41.67, implying about 81% upside. The analysis notes that growth expectations and risk perceptions drive the P/S discussion for biopharma, but the headline signal is clear: the stock looks undervalued on this framework.

ITT Inc.'s stock gains on ROE strength and earnings growth outlook

January 10, 2026, 7:59 AM EST. ITT Inc. shares have climbed about 6.5% in the past three months as investors weigh fundamentals. The company's ROE stood at 18% for the trailing twelve months through September 2025, with US$485 million in net profit on US$2.7 billion of shareholders' equity. That implies about US$0.18 profit per dollar of equity. The ROE sits above the industry average of roughly 11%, adding context to ITT's 26% five-year net income growth, versus about 16% for the sector. A three-year median payout ratio of around 23% suggests retention to fuel growth. The piece hints at valuation checks but does not commit to a fair price, leaving the verdict on future earnings growth to investors.

First Financial Bankshares underperforms over five years despite EPS gains

January 10, 2026, 7:58 AM EST. First Financial Bankshares (NASDAQ: FFIN) has fallen 21% over five years, even as its EPS rose about 5.3% per year. Revenue is up 2.7% in the period, but the stock's price performance remains weak. The trailing five-year TSR is -13%, with the dividend largely driving the gap between price return and overall return. In the most recent week, the shares rose 5.2%, and the company added about US$221 million to its market capitalization in the last seven days. Insider buying in the latest quarter provides a glimmer of optimism, but investors should focus on fundamentals. Over the year, FFIN is down 7.2% including dividends while the market is up 21%. A free report with consensus forecasts is available.

Helmerich & Payne: ROCE improving but still below energy services peers

January 10, 2026, 7:57 AM EST. Helmerich & Payne shows a 4.0% ROCE, below the energy-services industry average of 8.3% (ROCE = earnings before interest and tax divided by (total assets minus current liabilities)). The company has moved from loss-making five years ago to profitability, generating pre-tax income on capital. Capital employed is up about 28% over five years, signaling reinvestment opportunities. Shareholders have earned about 46% over five years. While the trend is improving, the stock carries risks and the article flags three warning signs. Analysts forecast further profitability; however, the firm still trails peers on returns. Investors should conduct further research to assess whether the current trend can persist.

Unico Silver fast-tracks Joaquin study; confidence grows but risk remains

January 10, 2026, 7:47 AM EST. Unico Silver advances the Joaquin project by moving straight from drill results to a pre-feasibility study, after reporting strong oxide silver-gold mineralisation from 31 holes at the La Negra SE prospect in Argentina. The company skipped a scoping study, arguing the project's scale, geometry and potential for conventional open-pit development justify a PFS-level mineral resource estimate. With funding secured for the PFS, near-term risk shifts from financing to execution-drilling, metallurgy and permitting. Yet the stock's huge 1-year run and a wide price-to-book divide leave room for disappointment if the PFS or further drilling underwhelm. Valuation assessments vary from extreme lows to several dollars, underscoring divergent views on risk and value.

Alamo Group to Increase Dividend to $0.34; 0.7% Yield Seen Sustainable

January 10, 2026, 7:46 AM EST. Alamo Group Inc. (NYSE: ALG) said it will raise its quarterly dividend to $0.34 on January 29. The new payment leaves the dividend yield at about 0.7%, a modest lift for income-focused investors. Before the announcement, the company easily covered the dividend, with cash flow supporting reinvestment in the business. Looking ahead, EPS is forecast to rise about 62.3% in the next year, possibly lifting the payout ratio to around 9.0% if the path continues-a level seen as sustainable. Since 2016, the dividend has grown from $0.32 to $1.36 annually, a roughly 16% CAGR. The history of steady payments and growing earnings over the past five years underpins Alamo Group as a potential income stock.

Analysts lift NEXT fair value; mixed views shape the NEXT investment story

January 10, 2026, 7:45 AM EST. Analysts nudged NEXT's central fair value from £142.72 to £146.07, tweaking the discount rate and revenue growth inputs. The moves reflect a split: some see more upside, others say much is already priced in. Bullish: Berenberg's Anne Critchlow raised targets to £180 with a Buy rating; Morgan Stanley's Grace Smalley lifted to €150 with an Overweight stance. Bearish/neutral: Citi's Monique Pollard to £139 with Neutral; JPMorgan to £130.30 Neutral. The divergence underlines ongoing valuation debates amid solid execution. NEXT reportedly weighs a potential bid for LK Bennett, likely focusing on the brand and digital assets. Guidance for 2025/26 shows full-price sales £5,603m, Total Group sales £6,971m, EPS 738.8p (vs 729.4p). For 2026/27: full-price sales £5,855m; Total Group sales £7,261m; EPS 770.4p, no buybacks.

Perpetua Resources momentum drives valuation questions; P/B at 6.9x vs peers

January 10, 2026, 7:44 AM EST. Perpetua Resources (TSX:PPTA) has surged on price momentum, prompting a closer look at valuation. The stock trades at CA$41.32 and a P/B (price-to-book) of 6.9x, historically rich relative to the Canadian metals and mining group (average ~3.2x) but below a higher peer mean (~14.6x). The model suggests the market prices in growth while balancing risk from it being loss-making, with net income of CA$44.29m and dependence on the Stibnite Gold project. Investors should compare against risk, upside, and a broad peer set. The current gap to analysts' targets implies some upside remains, but the valuation sits at a crossroad between asset quality and earnings visibility.

Charles River Laboratories: Valuation and Outlook Under Review After Rally

January 10, 2026, 7:43 AM EST. Charles River Laboratories International (NYSE: CRL) has jumped about 37% in recent months, trading near a yearly high. With broad analyst coverage, many near-term outlook shifts seem priced in. The stock appears fairly valued; a valuation model shows it trading around 12% below its intrinsic value, estimated at $250.32 a share, implying limited upside if that assessment holds. The piece notes the stock's high beta, i.e., greater price volatility, which could let the price sink if markets weaken. Forward earnings growth of about 7.7% is expected over the next two years, suggesting growth isn't the main short-term driver. Investors should weigh the balance sheet and other factors; since the stock hovers near fair value, a deeper pullback could offer a later entry point for buyers who can tolerate higher volatility.

Atmos Energy: ROE at 8.8% in line with industry as earnings grow

January 10, 2026, 7:42 AM EST. Atmos Energy's stock has fallen about 5.5% in the past three months. The company reports a trailing twelve-month ROE of 8.8% as of September 2025, based on $1.2 billion in net income and $14 billion in shareholders' equity. That equates to roughly $0.09 of profit per dollar of equity. Net income has grown about 14%, while the payout ratio sits around 47% with retention about 53%. The ROE is in line with the industry average of 8.8%, even as earnings growth outpaces the sector's 5.6% over the last five years. Investors will judge whether this growth is already priced in, and how the stock's valuation-via the price-to-earnings gauge relative to peers-fits the risk-reward.

Fiserv fair value $86.50 after Microsoft AI tie-up and Clover biometric payments

January 10, 2026, 7:32 AM EST. Fiserv (FISV) is back in focus after announcing a collaboration with Microsoft to embed more AI across its platforms, and a biometric payments rollout via Clover's partnership with Wink. The stock has tumbled over the past year, with a 12-month total return down 66.52% and a 90-day drop of 45.45%; the latest 30-day return is 4.53% and year-to-date 4.76%, around a US$68.71 share price. The analysis flags about a 54% intrinsic discount and roughly 26% below analyst targets, raising the question whether the stock is mispriced in payments and AI. Projections anchor a higher fair value on recurring software and services revenue and a margin reset from platforms such as Clover, Commerce Hub, Finxact and CashFlow Central. Fair value cited: $86.50 (UNDERVALUED). Risks include execution delays and margin pressure. The piece is by Simply Wall St.

SEBI to issue NOC to NSE, clearing path for IPO amid regulatory dispute

January 10, 2026, 7:31 AM EST. NEW DELHI – India's markets regulator is set to issue a No Objection Certificate (NOC) to the NSE this month, clearing the way for the exchange to prepare an IPO. SEBI said the approval will enable the NSE to draft its IPO prospectus, a key step amid a long-running dispute over access to trading. The watchdog fined the exchange 11 billion rupees in 2019 for inequitable access; NSE has sought a settlement, with Reuters reporting a potential $160 million deal. SEBI chair Tuhin Kanta Pandey told reporters in Chennai that the NOC would be issued soon, though broader friction between the two sides persists.

Alamo Group raises dividend to $0.34; yield remains modest

January 10, 2026, 7:30 AM EST. Alamo Group Inc. (NYSE: ALG) said its dividend will increase to $0.34 per share on January 29, from last year's payment. The dividend yield stands about 0.7%, below the industry average. Management projects next year's EPS to rise about 62.3%, with the payout ratio forecast near 9.0%, a level the team says supports sustainability. The company has a long dividend history, with payments climbing from $0.32 in 2016 to $1.36 in the most recent full year, reflecting roughly 16% annual growth. With earnings on an uptrend and ample cash, Alamo Group is framed as a potential income stock, though investors should compare opportunities beyond dividends.

AI-generated signals outline mixed near-term stance for ETHH:CA

January 10, 2026, 7:29 AM EST. AI-generated signals for the Purpose Ether ETF ETHH:CA were released January 10. The long-term plan calls for buying near 11.02 with a target of 14.53 and a stop at 10.96. A parallel short near 14.53 seeks a move to 11.02 with a stop at 14.60. The ratings for January 10 show Near: Weak; Mid: Strong; Long: Strong. The update includes a chart and a timestamp of January 10, 2026 07:04 ET. Readers are urged to review the AI-generated signals for ETHH:CA and apply appropriate risk controls given the mixed near-term signal.

Mettler-Toledo stock up 23% in year, outpacing market as EPS growth lags price gains

January 10, 2026, 7:28 AM EST. MTD has outperformed the market over the past year, with a roughly 23% rise versus about 19% for the market (price return, excludes dividends). Over three years, the stock is down about 4.7%. EPS grew 8.0% in the last 12 months, yet the share price gain outpaced this growth, signaling stronger investor sentiment. The report notes the CEO remuneration is modest for a company of this size. It also flags one warning sign investors should weigh as part of due diligence. For deeper insight, it points to a free interactive report on earnings, revenue and cash flow. In sum, twelve-month returns look positive, but longer-term performance remains mixed and hinges on growth in earnings and cash generation.

Duratec (ASX:DUR) Valuation Mixed as AUKUS Procurement Signals Lift Early Orders

January 10, 2026, 7:27 AM EST. Duratec (ASX:DUR) is in focus after being instructed to begin early procurement of long-lead items for AUKUS upgrades at HMAS Stirling, ahead of a FY26 main contract. The stock sits near A$2.00 after a recent run, with a 7% seven-day gain and 8% over the past month. Long-term momentum shows strong traction: 47% 1-year and more than 3x 5-year total shareholder returns. Analysts' fair value sits near A$1.97, suggesting a modest premium to the current price, while a DCF approach yields about A$2.16, implying value if deferral risks and costs stay contained. Risks include lumpy defence timing and rising costs that could compress margins. Readers should compare market pricing with their own assumptions.

XQLT AI signals flag long entry near 44.50; no short setup

January 10, 2026, 7:11 AM EST. The note provides a long-term view on XQLT:CA (iShares MSCI USA Quality Factor Index ETF). Traders are advised to buy near 44.50 with a stop at 44.28; there are no short plans at this time. The report also flags updated AI-generated signals for XQLT:CA, timestamped for freshness. AI ratings span horizons: Near – Strong, Mid – Weak, Long – Strong. A chart link for XQLT:CA is included. Byline: Chris, Contributor; Editor: Derek Curry.

Cboe Global Markets appears overvalued after rally, valuation signals caution

January 10, 2026, 6:59 AM EST. The stock closed at $260.95, with 5.2% weekly gains, 3.9% over 30 days, 5.2% YTD, 38.3% in 12 months, 117.7% in three years and 189.7% in five years. Simply Wall St assigns a 1/6 undervaluation score. An Excess Returns model yields an intrinsic value of about $203.51 per share. Using a Stable Book Value of $56.55 and a book value of $46.68, the model implies the stock is around 28.2% overvalued. The write-up also cites a Discounted Cash Flow view and notes the P/E ratio as a quick measure of price relative to earnings. Bottom line: the rally is attractive but valuation signals caution.

Verisk Analytics (VRSK) appears undervalued on DCF despite mixed recent results

January 10, 2026, 6:58 AM EST. Verisk Analytics (VRSK) sits near $224.87, with mixed returns: up 1.7% over the last week, 4.8% in the past month, up 1.7% year to date, but down 15.7% over a year. Three- and five-year gains stand at 24.6% and 22.2%, reinforcing a longer-term uptrend even as shorter horizons wobble. A six-point valuation checklist yields a 2/6, underscoring investor uncertainty. A 2-stage Free Cash Flow to Equity DCF, using trailing FCF about $1.09 billion and projections to about $2.18 billion by 2035, implies an intrinsic value around $266.04 per share and an undervalued stance with an intrinsic discount of roughly 15.5% at current levels. The stock's P/E of 34.26x sits above the industry average of 25.09x, signaling peers' higher growth or risk expectations.

Restaurant Brands International appears undervalued on DCF model, shares hover near $69

January 10, 2026, 6:57 AM EST. Restaurant Brands International (QSR) trades near US$69.00, after a week up 1.8% and a month down 2.5%. Over 1 year, the stock has gained 17.6%, and 5-year gains total 30.4%. Simply Wall St awards a valuation score of 3 out of 6. The article uses a DCF model – a two-stage Free Cash Flow to Equity approach – to estimate intrinsic value. Using analyst-driven cash flow forecasts, the model yields an intrinsic value of US$80.70 per share, implying the shares trade about 14.5% below fair value, i.e., undervalued according to this method. The piece also notes the P/E ratio as a shorthand for price relative to earnings. Context includes Burger King, Tim Hortons, Popeyes and Firehouse Subs amid a cautious consumer backdrop.

Stock Market Has Done This Only 3 Times in 155 Years – History Signals Caution for 2026

January 10, 2026, 6:56 AM EST. After a buoyant 2025, the Dow, S&P 500, and Nasdaq posted roughly 13%, 16%, and 20% gains. It marked the third time in almost a century that the S&P 500 has risen at least 15% for three straight years. Optimism is anchored in expected rate cuts, advances in AI and quantum computing, and a resilient economy. But stretches like these can precede reversals. One ultra-rare signal, seen only three times since January 1871, looms as a warning for 2026. Valuation debates endure. The Cyclically Adjusted Price-to-Earnings (CAPE) ratio uses 10 years of inflation-adjusted earnings to enable apples-to-apples comparisons and assess whether the S&P 500 is pricey, fair, or cheap.

Taiwan Semiconductor (TSMC): A Smart Growth Stock to Buy Now

January 10, 2026, 6:40 AM EST. Taiwan Semiconductor Manufacturing Co. (TSMC) sits at the center of the AI supply chain as the world's largest contract chip maker. Its fabless customers design chips and outsource production, making TSMC a neutral, cash-flow-rich beneficiary of AI growth rather than a pure-play on a single designer. At about 25x forward P/E, TSMC trades at a reasonable multiple given growth prospects. Wall Street expects roughly 31% growth in 2026 in NT$, with USD impact from currency moves. The AI buildout should keep demand for TSMC's nodes strong, and its major clients signal a bullish outlook. The company's trajectory suggests it is ahead of many peers in adopting AI infrastructure, though a sustained AI spending slowdown would temper gains. In short, TSMC offers AI exposure with a lower valuation hinge than fabless peers and solid upside if demand stays intact.

Campbell's CPB valuation tested after insider sale amid ongoing margin pressures

January 10, 2026, 6:39 AM EST. Campbell's CPB faces renewed scrutiny after executive vice president Charles A. Brawley III sold 11,550 shares worth $325,075. The move coincides with thin trading volume and ongoing margin pressures. The stock traded at $26.43, with a 30-day price decline of 6.21%. One-year TSR shows a 26.41% loss and a 3-year TSR loss of 46.02%, underscoring fading momentum despite dividends and buybacks. Analysts peg fair value above the current price, creating a valuation gap that depends on earnings growth, margins, and valuation multiples. Campbell's is pursuing cost savings and supply chain optimization, including a $375 million target, to lift margins and earnings over the next several years. Risks include sustained input-cost headwinds and continued volume softness in core soups and snacks. Investors can stress-test assumptions and compare to peers.

YETI Holdings: Mixed Valuation Signals as DCF Indicates Undervaluation

January 10, 2026, 6:23 AM EST. YETI Holdings trades around $49.34, with weekly gains near 10% and a year-to-date return of about 10%, though a five-year decline frames the longer picture. Investors weigh brand strength and product range against shifting consumer spending. Our checks show potential undervaluation: a Discounted Cash Flow (DCF) analysis – which estimates value by projecting future cash flows and discounting them to present value – returns an intrinsic value of about $94.43 per share, implying roughly a 47.8% gap to the current price. The stock trades at a P/E ratio (price-to-earnings) of 23.95x, roughly in line with the Leisure sector average of 22.63x, and below peers at 30.79x. Valuation is mixed, with risk tied to demand for premium outdoor goods.

Greggs (LSE:GRG) seen undervalued after DCF intrinsic value around £51 vs £16.36 share price

January 10, 2026, 6:11 AM EST. Greggs trades around £16.36, with a week drop of 2.4% and a one-year underperformance of 18.3%. The shares have fallen 28.6% over three years and are roughly flat over five years. The company remains a familiar UK food-on-the-go brand, with headlines focused on visibility and consumer reach, factors investors weigh when sizing long-term prospects. A Discounted Cash Flow (DCF) model, which values a business by discounting expected future free cash flows to today, points to an intrinsic value of £51.25 per share, implying the stock is undervalued by about 68%. Trailing twelve-month free cash flow sits near £39.9m; analysts project growth to £280.3m by 2029. The stock's P/E ratio reflects current earnings and growth expectations.

Commercial Metals: Q1 Beat, Growth Initiatives Drive Valuation Debate

January 10, 2026, 6:07 AM EST. Commercial Metals beat expectations in Q1 as higher steel margins and stronger construction demand support earnings, aided by acquisitions of CP&P and Foley in December. The company also announced its 245th consecutive dividend of US$0.18 and pushes ahead with micro mill capacity expansion. The stock has climbed about 27% in 90 days and 56% over the past year, raising questions whether the implied discount to consensus reflects value or already priced-in growth. The narrative centers on steadier revenue, margin gains, and a lower forward multiple versus peers, with a fair value around US$74 versus a recent close near US$72.46. Risks include higher rates, tariffs, and rebar capacity pressure that could compress pricing and margins. The market trims the P/E gap only slowly.

Safran valuation check after mixed short-term moves and strong multi-year returns

January 10, 2026, 5:56 AM EST. Safran (ENXTPA: SAF) has eased about 0.7% on the latest session after a string of gains. The stock trades at €317.3, with a narrative fair value around €328.67, suggesting a modest upside. A separate SWS DCF model puts fair value at €286.43, implying the shares could be considered expensive on cash flows. Recent actions, including the Collins actuation and flight-control assets deal, expand Safran's offering and could lift EBIT margins and diversify revenue through 2028, even as investors weigh risks. Key risks include supply-chain bottlenecks and potential changes in airline or airframer terms. The full narrative lays out growth paths and margins needed to bridge to the €328.67 fair value.

Nasdaq Valuation in Focus Ahead of 2025 Results; Mild Undervaluation vs Peers

January 10, 2026, 5:55 AM EST. Nasdaq (NDAQ) is set to report fourth-quarter and full-year 2025 results on Jan. 29, 2026, with investors watching trading volumes and listings updates. The stock trades at $98.24, up about 6.9% in 30 days and 31% over the past year. The narrative sees a fair value near $104, implying a mild undervaluation of roughly 5.5%. Analysts' average target sits around $100.67, though bets range from $74 to $115. Nasdaq's current P/E ratio is about 34.5x, above peers at ~32x and the US Capital Markets industry average of 25.6x, well above a longer-run fair value of ~16.7x. The price supports potential upside, but risks include tougher competition in exchange/fintech services and slower client decision-making.

Humana (HUM) valuation check: mixed returns, price near fair value but DCF gap wide

January 10, 2026, 5:54 AM EST. Humana's stock shows mixed momentum. In the last week, HUM is up 4.68%; over 30 days, up 7.87%. Yet three- and five-year total shareholder returns are 41.78% and 28.76%, modest for a large insurer. The shares trade around $276.85, vs an implied target of $288.42 and a narrative fair value of about $287.38, signaling a small pullback versus price but modest upside in a steady earnings rhythm. Analysts' targets span roughly $250 to $353, with a consensus near $299. A separate discounted cash flow (DCF) model places fair value near $999.29, implying about a 72% discount to that figure and a much larger valuation gap. Key risks: Medicare Advantage star ratings disputes and margin pressure from coding/reimbursement changes. See how DCF inputs shape the spread.

MGIC Investment (MTG) Valuation Signals Undervalued After Multi-Year Rally

January 10, 2026, 5:53 AM EST.MGIC Investment trades around $29.01. In the last year the stock rose 29.4%, while 3-year gains reach 134.9%; 7-day and YTD moves sit modestly negative. The insurer is a focal point in US mortgage risk, with housing and credit cycles shaping sentiment. MGIC Investment scores 5 of 6 on valuation. An Excess Returns model anchors an intrinsic value of $74.47 per share, implying the stock is about 61% undervalued versus the current price. The analysis also uses a price-to-earnings view and a Jan 2026 discounted cash flow case, among other checks, to map fair value. Overall, the pieces point to a substantial gap between price and calculated value for MTG.

Elevance Health (ELV) Undervalued on DCF Despite Price Weakness

January 10, 2026, 5:52 AM EST. Elevance Health (ELV) closed at $372.83, with returns of +5.2% last week, +9.3% last month, +5.2% year to date, and mixed longer-term figures (−0.3% over the past year; −19.2% over three years; +22.2% over five). The stock earns a 5/6 score for being undervalued across valuation checks. A Discounted Cash Flow (DCF) model puts intrinsic value at about $1,011.50 per share, implying roughly a 63.1% discount to the current price. The analysis relies on a two-stage Free Cash Flow to Equity forecast, with ~$3.6 billion in trailing FCF and projected ~$8.98 billion by 2030. A P/E framework is also cited as a yardstick for a profitable insurer, while sentiment around large US health insurers remains influenced by risk and growth expectations.

AstraZeneca: DCF signals undervaluation against five-year run

January 10, 2026, 5:51 AM EST. AstraZeneca plc (LSE:AZN) trades around £142.16, after a five-year run that has delivered 110% total return. Recent moves include 7-day gains of 4.6% and 1-year gains of 32%. Headlines over its pipeline, regulatory developments and broader drug-maker dynamics keep the stock in focus. The company's valuation score sits at 3 of 6, signaling mixed signals about value. A Discounted Cash Flow (DCF) analysis from Simply Wall St puts an intrinsic value of £250.77 per share, versus the current price, implying a 43% discount and an undervalued read on this metric. The model uses a two-stage Free Cash Flow to Equity forecast; last twelve months FCF is US$10.24b, rising to US$12.11b in 2026 and US$21.68b by 2030. A P/E lens is noted as investors weigh growth against resilience.

AI-Generated Signals for ZRR:CA Update, January 10, 2026

January 10, 2026, 5:35 AM EST. On January 10, 2026, AI-generated signals were updated for the ZRR:CA – the BMO Real Return Bond Index ETF. The notice shows a Short near 14.38, with no target and a stop loss at 14.45; no Long plans are offered. A ratings table for January 10 lists Near as Weak, Mid and Long as Neutral. The update notes a timestamp and directs readers to the AI-generated signals for ZRR:CA. The content reads as a brief signals summary rather than a full research note, emphasizing a time-stamped data point and a link to the full AI-generated chart.

DroneShield stock in focus after JPMorgan crosses 5% line; ASX:DRO ends week above A$4

January 10, 2026, 5:25 AM EST. DroneShield shares rose after JPMorgan Chase disclosed a 5.09% stake, crossing the 5% threshold on Jan. 7 in a Jan. 9 filing, about 46.5 million shares. The disclosure follows a late-2025 governance selloff that dented confidence. JPMorgan's holding spans trading, prime brokerage and stock-lending, meaning some shares may be loaned out, and sentiment can shift quickly. The stock closed Friday at A$4.02; ASX trading resumes Monday. DroneShield flags Q1 deliveries and cash receipts ahead of February audited results, including an A$8.2 million western military order and about A$97.7 million in "locked in revenues" for 2026, plus a A$49.6 million European reseller contract to be delivered in Q1 2026. Attention will stay on cash conversion, margins and timely cash collection.

Bytes Technology Group: Institutions Dominate Ownership as BYIT Rebounds After 6.4% Annual Loss

January 10, 2026, 5:21 AM EST. Bytes Technology Group plc (LON:BYIT) shows heavy institutional ownership, with about 79% of shares held by institutions. Six investors control a majority stake, totaling roughly 51%, while the largest holder is Coronation Fund Managers Limited with a 26% stake. Biltron (Pty) Ltd and Camissa Asset Management Proprietary Limited own 7.7% and 5.1% respectively. The company is not hedge fund-owned. Last week, the stock added about UK£41 million to its market capitalization after a year in which the shares fell 6.4%. Because institutions own the bulk of the stock, their trading can move the price more than a typical holder; there is also a risk of a crowded trade if several large holders act together. The top six own more than half, signaling concentration that could shift with new data.

LSEG stock rises as buyback rolls on ahead of Feb results

January 10, 2026, 5:20 AM EST. London shares in line with a buyback-fuelled lift. London Stock Exchange Group (LSEG.L) closed up 1.1% after a midweek dip, as the company extended its buyback, buying 112,659 shares at an average 8,876.35 pence amid a programme that could run to 1 billion pounds and end by Feb. 25. The latest purchases followed 117,644 shares bought at 8,941.89 pence. The move comes as the FTSE 100 hit a record high on U.S. jobs data that kept rate-cut expectations alive. LSEG trades in a 52-week range of 8,096-12,185 pence. Investors will watch U.S. inflation data on Tuesday and LSEG's preliminary results on Feb. 26 for earnings growth and volume trends.

Intel stock climbs on political support and product momentum; is it too late to buy?

January 10, 2026, 5:04 AM EST.Intel's shares rose after Washington provided a strategic backstop and the company showcased new products at CES. The U.S. government agreed in August to buy 433.3 millionIntel shares at $20.47, a 9.9% stake, underscoring policy support as the stock trades above $45, more than double the purchase price. Trump publicly praised CEO Lip-Bu Tan after a White House meeting, boosting sentiment though not a guaranteed edge. In the latest quarter, Intel posted $13.7 billion in revenue, up 3% year over year, with margins improving as costs were trimmed and demand outpaced supply, a trend Intel says could persist into 2026. The company also aims to rebuild in-house fabrication with Panther Lake and the 18A process unveiled at CES, but execution remains key.

Rio Tinto price strength clashes with valuation signals (LSE:RIO)

January 10, 2026, 5:03 AM EST.Rio Tinto Group (LSE:RIO) is back in investor focus after a price run that pushed the stock to £60.06. In the near term, the one-day return of 3.04% adds pressure, while the 30-day gain of 7.12% and a 1-year total shareholder return of 32.38% point to building momentum. Two valuation views clash: a popular narrative pegs the stock about 5% overvalued at current levels relative to a £57.09 fair value, suggesting limited upside. A DCF model puts fair value at £83.82 and implies roughly 28% upside from the price. The spread matters as weaker commodity pricing or project execution and regulatory risks could affect margins and cash flow. Investors should weigh near-term momentum against these divergent assumptions.

XIN: CAD-hedged EAFE signals point to long-term buy near 38.37 with 38.18 stop

January 10, 2026, 4:52 AM EST. The note tracks XIN:CA, the CAD-hedged version of the iShares MSCI EAFE Index ETF. Updated AI-generated signals flag a long-term buy near 38.37, with a stop loss at 38.18; there are no short plans at this time. The update, dated January 10, 2026, also shows a ratings matrix across Near, Mid and Long horizons with labels such as Strong, Weak and Neutral. The data carry a timestamp cue, reminding readers to verify the moment of generation. The content is presented as signals, not a binding investment recommendation.

Three historical correlations point to a 2026 market pullback under Trump, amid AI optimism

January 10, 2026, 4:51 AM EST. Three historical correlations weigh on 2026 for the three main U.S. benchmarks: the Dow, the S&P 500, and the Nasdaq Composite. The piece cautions there is no single indicator that can predict short-term moves. Still, past episodes show how big drops follow extended rallies. The S&P 500 posted a 16% gain in 2025, the third straight year with at least 15% gains, a streak only seen before the late 1990s and 2019-2021 and 2023-2025. The prior dot-com bubble burst and the 2022 bear market illustrate how lofty valuations can unwind. With arguments about lower interest rates and the AI revolution, the author notes three historically accurate correlations that raise the odds of a correction or crash in 2026, even as policy and tech trends provide upside.

ASICS (TSE:7936) stock may be overvalued after multi-year rally, according to DCF

January 10, 2026, 4:50 AM EST.ASICS trades at ¥4,142 on the Tokyo Stock Exchange, up 10.3% in 7 days, 10.6% in 30 days, 7.6% year-to-date and 28.4% over 12 months. The 3-year return is large and the 5-year gain is roughly eightfold. Despite the rally, the stock scores 0/6 on valuation checks. A 2-stage Free Cash Flow to Equity DCF model from Simply Wall St yields an intrinsic value of ¥3,215.31 per share, implying the shares are about 28.8% overvalued versus the current price. The model uses a trailing FCF of ¥85,544.14 million and projects to 2035, with ~¥131,200 million in 2029. The stock also trades at a P/E of 34.46x, signaling a stretched multiple against the outlook.

Ryanair stock overvalued on DCF; price €29.10 vs €25.73 intrinsic

January 10, 2026, 4:49 AM EST. Ryanair Holdings last closed at €29.10, up 3.2% on the month and up 92.3% over five years. A two-stage DCF using Free Cash Flow to Equity points to an intrinsic value of €25.73, about 13.1% below the current price, i.e., overvalued on this metric. The stock trades at a P/E of 12.95x, higher than the Airlines industry average of 9.49x but below the peer group average of 16.30x. The latest twelve-month (TTM) FCF runs around €1.8 billion. Our valuation checks score 1/6. Investors should weigh growth expectations, risk factors like fuel costs and demand, and how Ryanair's network scale and cost structure stack up against peers.

TotalEnergies (TTE) appears undervalued after price weakness, DCF signals

January 10, 2026, 4:48 AM EST. TotalEnergies closed at €55.12, down 1.7% in the past week and 1.3% over 30 days. The shares are up 6.0% over the last year but have lagged in other horizons. Simply Wall St scores its valuation 5 of 6. A two-stage DCF using US$ cash flows puts an intrinsic value of €203.04 per share, about 73% above the current price. Forecasts project free cash flow to rise from about US$14.2b trailing to around US$19.9b by 2030, with volatility in between. The model flags the stock as undervalued on a cash-flow basis; P/E considerations are less clear given energy-market risk and mix. Bottom line: the valuation story supports a longer-term case, but near-term risks deserve scrutiny.

Star Bulk Carriers (SBLK) undervalued after five-year rally, DCF fair value near $111

January 10, 2026, 4:47 AM EST.Star Bulk Carriers trades at $19.64, with a year-to-date gain and a five-year surge of about 199%. The stock has drawn attention as investors weigh freight rate cycles and fleet capacity against risk and cash generation. A DCF, or discounted cash flow, model points to a fair value near $111 per share, implying an 82% premium to the current price. The model uses a two-stage FCFE (free cash flow to equity) approach; trailing FCFE runs around $237 million, with projections toward roughly $1.5 billion in 2035. Simply Wall St assigns a 3/6 value score, noting the stock appears undervalued on about half of the checks. In short, the market price versus estimated cash flows suggests upside, though pace and sector cycles merit caution.

Dollar climbs as rate-cut bets fade on mixed data and tariffs risk

January 10, 2026, 4:33 AM EST. Dollar index (DXY) rose to a one-month high, finishing up 0.2% as mixed US data kept Fed rate-cut bets modest. Payrolls rose less than expected, but the unemployment rate fell and wages rose, reinforcing a hawkish tilt. The University of Michigan sentiment index beat forecasts, and a Supreme Court decision delaying tariffs added policy ambiguity. In December data, payrolls rose 50,000; unemployment 4.4%; wages +3.8% y/y. Oct housing starts fell 4.6%. Markets price about a 5% chance of a -25 bp cut at the FOMC meeting on Jan 27-28. The dollar faces headwinds from expected Fed easing of about 50 bps in 2026, plus the BOJ hikes and an ECB pause; liquidity moves and talk of a Trump-appointed, dovish chair cap the upside.

Dow Jones Futures Tick Higher Ahead of Jobs Data; AI Spending and Weekly Gains in Focus

January 10, 2026, 4:31 AM EST. U.S. stock futures edged higher ahead of Friday's jobs data as traders weigh the official payroll release against political timing. The Bureau of Labor Statistics said 473,000 jobs were added from February through December, the slowest pace outside a recession since 2003, with government payrolls down and private sector hiring driving the gains. Separately, investors weigh AI capex as a growth engine. Hyperscalers Microsoft, Alphabet, Amazon, Meta and Oracle are projected to spend more than $500 billion on AI infrastructure this year, a cycle that could slow if spending wanes but be sustained by an ultra-accommodative Fed. For the week, the Dow, Nasdaq and S&P 500 rose about 2.3%, 1.9% and 1.6% respectively, signaling continued appetite for risk.

Firan Technology Group stock crosses above 50-day moving average

January 10, 2026, 4:30 AM EST. Firan Technology Group Co. (TSE:FTG) shares crossed above its 50-day moving average on Friday. The 50-day line stands at C$11.23, with a session high of C$13.42; FTG was last at C$13.40 on volume of 145,523. Key metrics show a current ratio of 2.54, quick ratio 1.53 and a debt-to-equity ratio of 50.28. Market capitalization is about C$337.3 million, with a P/E of 23.93 and beta of 1.05. The 200-day MA is C$11.48. In the latest quarter, FTG reported C$0.12 earnings per share (EPS) on revenue of C$47.74 million; ROE 16.22% and net margin 6.47%. Analysts expect about 0.420 EPS this year. Insiders: Director Bourne bought 7,500 shares at C$10.00, boosting holdings to 2,759,966 shares (32.64% of the company).

WPP Upgraded to Hold by Wall Street Zen; mixed analyst ratings persist

January 10, 2026, 4:26 AM EST. Wall Street Zen upgraded WPP from sell to hold on Saturday, adding to mixed analyst signals. Zacks Research had earlier moved WPP from strong sell to hold (Dec 29). Weiss Ratings remains sell. MarketBeat shows one Buy, three Hold and two Sell ratings, with a consensus of Reduce. Shares opened at $23.69; the 52-week range is $17.47 to $49.12. The stock sits around the 50-day moving average near $20.78 and below the 200-day moving average at $24.76. Institutions added to holdings: GAMMA Investing LLC 1,254 shares; Caitong International Asset Management opened a position; SBI Securities Co. Ltd. 1,454 shares; Allworth Financial LP 1,852; Osaic Holdings Inc. 1,395. About WPP: WPP plc is a British multinational advertising and public relations company.

Commercial International Bank Egypt stock up 3.8% on LON:CBKD

January 10, 2026, 4:25 AM EST. Commercial International Bank (Egypt) S.A.E. (LON:CBKD) rose 3.8% on Friday, trading as high as GBX 2.41 and last at GBX 2.35. About 1,900,258 shares changed hands, up 82% from the average daily volume of 1,045,909. The stock closed the prior session at GBX 2.26. The bank's 50-day simple moving average sits at GBX 2.21 and the 200-day at GBX 2.02. Market capitalization stands at £70.29 million; price-to-earnings, logged as 0.00, and a beta of 0.56. CIB Egypt operates in four segments: Corporate Banking, Investment, Retail Banking, and Assets & Liabilities Management, offering accounts, deposits, loans, cards, and digital banking services. The move reflects liquidity dynamics and regional risk factors affecting the stock's trajectory.

First BanCorp. stock crosses above 200-day moving average as analysts adjust targets

January 10, 2026, 4:24 AM EST. First BanCorp. (NYSE: FBP) rose Friday after trading above its 200-day moving average of $21.11, hitting a high of $21.87 and last at $21.46 on volume of 1,457,959. The stock's 50-day moving average is $20.56. Several analysts cut targets: Wells Fargo to $23 with an overweight rating, Truist to $24 with a buy rating, UBS to $25, and Keefe, Bruyette & Woods to $24 with a market perform view. MarketBeat shows an average rating of Moderate Buy with a $24 target. The company reported $0.51 EPS on $248.71 million in revenue, beating consensus by $0.03. It declared a quarterly dividend of $0.18, an annualized yield of about 3.4%; ex-dividend date was Nov. 28. Institutional trading included GAMMA Investing LLC purchasing a new stake.

U.S. stocks hit records as payroll data delays Fed rate-cut path; Vistra and Oklo lift on Meta deals

January 10, 2026, 4:23 AM EST. U.S. stocks closed higher, with the S&P 500 up 0.6% to a fresh record and the Dow posting gains as the Nasdaq rose about 0.8%. The Labor Department showed December hiring missed economists' forecasts, though the unemployment rate improved, underscoring a 'low-hire, low-fire' backdrop that may delay another Fedrate cut but does not close the door. Vistra jumped roughly 10% after a 20-year power-supply deal to Meta Platforms for three nuclear plants. Oklo climbed about 8% after signing a deal with Meta to secure nuclear fuel for a project in Pike County, Ohio. Energy and tech deals are shaping sentiment as investors weigh policy and growth.

Perma-Fix PESI crosses above 200-day moving average; earnings beat revenue estimates

January 10, 2026, 4:22 AM EST. Perma-Fix Environmental Services (NASDAQ:PESI) crossed above its 200-day moving average on Friday, with the benchmark at $11.92. The stock traded as high as $14.39 and was last quoted at $14.19 on volume of 99,997 shares. The move comes as Weiss Ratings reaffirmed a sell rating on Oct. 8, and MarketBeat shows an overall Sell consensus. The company's market cap sits around $262.8 million, with a negative P/E of -21.50 and a beta of 0.38. The stock's 50-day moving average is $13.10; debt-to-equity 0.03; quick ratio 1.72 and current ratio 1.77. In the latest quarter, PESI posted EPS of -$0.10 on revenue of $17.45 million, beating estimates of -$0.12 and $16.30 million; net margin -19.15%; ROE -19.45%. Several institutions added to their positions.

Geospace Technologies stock crosses above 200-day moving average; analysts diverge

January 10, 2026, 4:20 AM EST. Geospace Technologies Corp (GEOS) crossed above its 200-day moving average on Friday. The 200-day MA sits at $18.03, with an intraday high of $22.35 and the last trade at $21.89 on 308,296 shares. The company reported Q3 EPS of -$0.71 and revenue of $30.71 million; ROE was -7.26% and net margin -8.78%. Market capitalization stands at $282.16 million with a P/E of -28.43 and a beta of 0.48. On the ratings front, Wall Street Zen trimmed the stock to Hold; Weiss Ratings kept a Sell (d-); MarketBeat shows an average Sell rating. Institutional investors own 57.15%; buyers include First Eagle Investment Management, Grace & White, Strs Ohio, among others.

CLS stock slips below 200-day moving average; price near GBX 60

January 10, 2026, 4:19 AM EST. CLS Holdings plc (LON:CLI) traded below its 200-day moving average on Friday. The moving average is GBX 61.24, with a low of GBX 59.10; CLS was last at GBX 60.51 on volume 240,647 shares. Analysts are mixed: Peel Hunt reiterates a hold with a GBX 70 target; Berenberg maintains a buy rating and a GBX 70 target. MarketBeat shows an overall Moderate Buy and a consensus GBX 70 target. The balance sheet shows a quick ratio of 0.59, current ratio 0.73, and debt-to-equity 123.30; the 50-day MA is GBX 59.04. Market cap is about £241 million; P/E is -4.23, beta 1.01. CLS describes itself as a commercial property investor with a portfolio across the UK, Germany and France.

Record plc shares dip below 200-day moving average (LON:REC)

January 10, 2026, 4:18 AM EST. Record plc (LON:REC) slipped below its 200-day moving average on Friday. The stock touched as low as GBX 53, versus a 200-day average of GBX 58.50, and last traded at GBX 55.50 on volume of 230,871 shares. The near-term 50-day moving average sits at GBX 55.43. Market data show a market cap of about £107.20 million, a P/E ratio of 12.97 and a beta of 1.05. Leverage metrics include a debt-to-equity ratio of 0.64; liquidity ratios show quick 4.03 and current 4.35. The company reported EPS of GBX 1.93 in the latest quarter. Analysts currently forecast roughly GBX 4.69 for the current year, and the stock carries a Hold rating from most analysts.

Corn Holds Steady on Friday as Export Commitments Rise Ahead of WASDE

January 10, 2026, 4:16 AM EST.Corn futures held steady on Friday, with some contracts fractionally lower at midday. The CmdtyView national average cash price was steady at $4.07 1/2. After Thursday's Export Sales report, US corn export commitments rose to 50.895 MMT as of January 1, about 30% above a year ago, and at 63% of USDA's current projection, above the 61% average pace. Shipments reached 27.414 MMT, about 34% of USDA's forecast and ahead of the 24% normal pace. South Korean buyers tendered for 339,000 MT. WASDE due Monday; Bloomberg expects stocks near 1.985 billion bushels, down about 44 million if realized. Nearby and deferred futures sit near unchanged.

Owens Corning faces institutional pullback as Zacks Strong Sell weighs on near-term outlook

January 10, 2026, 4:03 AM EST. Owens Corning faces renewed scrutiny as institutional exposure dims. Paradiem LLC trimmed its OC stake by 58,221 shares, removing about $9.3 million from its position, even as analysts cut earnings and revenue forecasts and Zacks assigns a Strong Sell. The move sharpens focus on whether the near-term results align with Owens Corning's longer-term building materials narrative. Investors must believe in the long-term need for energy-efficient, resilient products and the company's ability to earn through cycles. The near-term catalyst remains execution on higher-margin, differentiated offerings; the main risk is prolonged softness in North American housing and R&R demand. Zacks Rank 5 underscores lower forecasts for the current and next year. Forecasts show about $11.5B revenue and $1.6B earnings by 2028, with a fair value around $140.56 and roughly 15% potential upside amid overcapacity risk.

Genel Energy crosses below 200-day moving average as shares hover near GBX 58

January 10, 2026, 4:00 AM EST. Genel Energy plc (LON:GENL) traded below its 200-day moving average on Friday, as the stock slid to a session low of GBX 55.70 and last finished around GBX 57.60 on volume of 177,539 shares. The 200-day line sits at GBX 62.58, with the 50-day at GBX 59.14. Jefferies Financial Group lifted its price target on Genel Energy to GBX 90 and reiterated a Buy rating in a note dated Monday, October 20. MarketBeat shows two Buy-rated analysts and an average target of GBX 85. Genel carries a market cap of about £158.6 million, a negative P/E (-2.92) and a peg near zero (-0.03); debt-to-equity 59.32, current ratio 5.26, quick ratio 5.87, beta 1.13. Insider Yetik Mert sold 39,507 shares at an average price of GBX 58 on Nov 28, for about £22,914; insiders own 26.33%.

Utz Brands nears $10 as DCF points to upside amid mixed valuation

January 10, 2026, 3:47 AM EST. Utz Brands trades around $9.94 after a prolonged bear market. The stock is down about 52% over five years and has been weaker than peers this year. Recent coverage focuses on its role in packaged snacks and how its brand portfolio aligns with consumer trends, while management decisions on growth and balance-sheet discipline remain in focus. The stock carries a valuation score of 3 out of 6. A Discounted Cash Flow (DCF) model-2-stage free cash flow to equity-points to an intrinsic value of about $11.19 per share, suggesting roughly 11.1% undervaluation versus the current price. Beyond DCF, the price-to-sales (P/S) ratio is used to compare sales dollars to value, noting margins and non-cash items. In sum, UTZ looks potentially attractive, but valuation is mixed.

Core Lithium's cautious Finniss restart refines capital discipline amid lithium price rebound

January 10, 2026, 3:46 AM EST. Core Lithium is pursuing a cautious Finniss Restart, keeping the project on care and maintenance as lithium prices rebound on tighter supply and rising demand. The approach aligns disciplined capital management with an expected market upswing, renewing investor focus on the company's narrative. The March 2025 Finniss Restart Study, which targets optimising BP33 and processing efficiencies, sits at the centre of the decision timetable and potential cost trajectory. Even with a price rebound, the near-term risk remains: extended downtime and ongoing care and maintenance costs could pressure cash during delays or softer prices. Valuation takes a mixed view: several fair-value estimates frame CXO between narrow and wide ranges, underscoring uncertainty around a commercial restart and long-term cash generation. Source notes from market watchers caution against over-optimism.

Halozyme Therapeutics appears undervalued on DCF and P/E signals

January 10, 2026, 3:45 AM EST. Halozyme Therapeutics trades at $72.45, with 7-day, 30-day and 1-year gains shaping investor expectations. A Discounted Cash Flow model using a 2-stage Free Cash Flow to Equity framework puts the intrinsic value around $201.82 per share, about 64% above the current price, suggesting the stock is undervalued. The company's P/E ratio of 14.31x sits below the Biotechs industry average of 21.08x, reinforcing the valuation gap. Halozyme carries a value score of 5 out of 6 in the assessment, with recent licensing and partnership updates providing context for earnings visibility. While DCF signals upside, outcomes depend on execution of collaborations and regulatory timing, keeping risk balanced against potential payoff.

Paragon Banking Group shares rise above 200-day moving average

January 10, 2026, 3:43 AM EST. Paragon Banking Group PLC crossed above its 200-day moving average on Friday, trading near GBX 881 with volume 215,502. The 200-day moving average is GBX 873.02. The company has a market capitalization around £1.67 billion, and trades on a P/E of 10.02, a PEG of 0.50, and a beta of 1.52. Analysts lifted targets: RBC to GBX 1,050 with an outperform rating, and Shore Capital to Buy with a GBX 1,000 target. The consensus is a Moderate Buy, with a target price of GBX 1,016.50. A share buyback was approved, and insiders bought a total of 63,716 shares in the last 90 days. Paragon is a UK specialist bank focusing on landlords, SMEs and residential property developers.

Cattle futures slip as cash trade strengthens; APHIS flags screwworm cases in Mexico

January 10, 2026, 3:30 AM EST.Live cattle futures are slipping at midday, down about $1.50-$1.70, as cash trade grows with North bids near $233 and South bids around $232; the Fed Cattle Exchange posted no sales. Feeder cattle futures fall $2.30-$3.60, while the CME Feeder Cattle Index climbs to $368.07 on January 7. The APHIS update shows more active New World Screwworm cases in several Mexican states, including Tamaulipas and San Luis Potosi. USDA boxed beef prices were lower: Choice at $355.24 and Select at $351.44. Thursday slaughter was 117,000 head; week-to-date totals stand at 465,000, about 10,700 below a year ago. Nearby futures quotes: Feb/Apr/Jun Live Cattle and Feb/Mar/Apr Feeder Cattle.

S&P 500 posts 13.5% annual return over decade; Wall Street expects ~10% in 2026

January 10, 2026, 3:29 AM EST. Over the last decade, the S&P 500 returned 13.5% a year excluding dividends (15.5% including). Cumulative gains were about 256% ex-dividends and 323% with dividends. The 30-year averages sit lower: about 8.4% (ex) and 10.4% (incl), a guide to forward returns. SIFMA data show nearly 5,500 listed companies across U.S. exchanges as of Q3. The index, created in 1957, tracks 500 large U.S. companies and is rebalanced quarterly, though additions can occur anytime; recent inclusions include CRH, Carvana and Comfort Systems. Top weights: Nvidia, Apple, Microsoft, Alphabet and Amazon. Wall Street targets for 2026 put the S&P around 7,400-8,100, implying upside to today's level near 6,922 of roughly 7-17%.

Cogent Communications Holdings (CCOI) may be undervalued after a 1-year 65.9% decline, DCF shows

January 10, 2026, 3:28 AM EST. Cogent Communications Holdings (CCOI) trades near $22.94, having fallen 65.9% in the last year. Over the past week it gained 11.3% while 30-day results slipped 3.7%. A DCF model using a 2-stage free cash flow to equity projects an intrinsic value of $42.39, suggesting the stock is about 45.9% undervalued. Trailing twelve months free cash flow is a loss of $158.2 million, with projected positive cash flow resuming in 2026 ($36.0 million) and rising to $228.3 million by 2035. The stock carries a valuation score of 5/6 from Simply Wall St, reflecting questions about demand for core telecom infrastructure, growth, capital intensity and competition.

Figma stock seen as bargain after IPO slump amid AI push

January 10, 2026, 3:13 AM EST. Figma, the cloud-based UX/UI software maker, has seen a brutal post-IPO rout. The stock began at $33 in July, surged to a peak near $143, and now trades around $37.33, down about 75% from the high. IPO volatility has persisted; two quarterly results since the debut disappointed the market, though underlying revenue grew. With a market cap near $19 billion, the shares look cheap versus Adobe's $20 billion bid that preceded the deal's antitrust breakup, and the AI hype adds a bullish backdrop. Figma frames itself as AI-friendly for design tools: Make, Sites, Buzz, and the Weave rebrand signal a push into AI-assisted UX/UI. In Q3, revenue rose 38% to $274.2 million, underscoring ongoing growth amid scrutiny.

MAS opens Nasdaq dual-listing consultation; SGX stock eyes Global Listing Board

January 10, 2026, 3:12 AM EST. Singapore's central bank opened a public consultation on legal changes to ease dual listings between SGX and Nasdaq, backing a planned Global Listing Board on SGX. The package would let issuers use a single prospectus across markets, tighten Singapore's registration timeline, and introduce safe harbours for forward-looking statements and share buybacks. SGX RegCo also proposed a minimum market cap of S$2 billion for the new board and a requirement to reserve 5% or S$50 million for designated retail brokerages. Feedback is due February 8; SGX reports results on February 5. SGX shares rose 1.16% to S$17.51, trading near the top of a 52-week range; the 50-day moving average sits around S$16.94. Analysts say real impact hinges on early deal flow and liquidity.

Luckin Coffee LKNC.Y valuation under pressure after mixed growth signals

January 10, 2026, 2:57 AM EST. Luckin Coffee (OTCPK: LKNC.Y) trades around $33.12 as recent trading pressure weighs on the name. One-day return down 2.3%, 30-day return down 10.3%. Yet the longer horizon looks sturdier: 1-year total shareholder return around 36.1% and five-year TSR about 3x. Revenue growth clocked 16.4%; net income growth about 19.7%. The market price sits below a widely cited fair value of $49.63, implying an undervalued setup on that narrative. Proponents point to ongoing vertical integration and a new Xiamen roasting facility to lift margins. But a separate view from SWS places fair value at $29.57, suggesting the stock could be overvalued at current levels. Key risks: rapid store rollout raising costs and intense local competition. Readers should weigh which scenario matches their assumptions.

Corn futures ease on Friday as March leads weekly gain ahead of USDA data

January 10, 2026, 2:45 AM EST.Cornfutures eased on Friday as markets squared positions ahead of Monday's USDA Grain Stocks report. The active March contract rose for the week, closing up 8.25 cents, while nearby cash corn slipped 0.25 cents to $4.0725 per bushel. US commitments were 50.895 MMT (million metric tons) as of Jan. 1, up about 30% from a year earlier and about 63% of the USDA projection; shipments reached 27.414 MMT, about 34% of the forecast and above the 24% normal pace. South Korean buyers tendered for 339,000 MT. The USDA Stocks report is due Monday; a Reuters survey pointed to Dec 1 stocks at 12.962 bbu (billion bushels), within a wide range. The CFTC data showed managed money trimming the net short in corn futures to 16,426 contracts as of Jan 6.

Live and feeder cattle futures slide; cash trade steady, boxed beef mixed

January 10, 2026, 2:44 AM EST. Live cattle futures fell on Friday, with most contracts down about $1 to $1.55 and February expiry fading around $2.27 for the week. Cash trade was reported at $232-233 per hundredweight across the country. The Fed Cattle Exchange online auction produced no sales, with bids near $230-231. Feeder cattle futures slid $1.75 to $3.60, though January led gains for the week, up about $4.63. The CME Feeder Cattle Index dipped 17 cents to $367.90 as of Jan. 8. CFTC data show managed-money funds increased their net long in live cattle futures and options to 94,761 contracts, while feeders added to a 16,838-contract net long. USDA boxed-beef prices were mixed; Choice down to $355.63, Select up to $352.17. Week-to-date slaughter at 553,000 head, 38,422 below last year.

Hogs slip Friday as lean futures retreat; cash price falls; cutout weak

January 10, 2026, 2:43 AM EST. Lean hog futures finished Friday with losses ranging from 15 cents to $1.425. The national cash market base hog price fell $2.31 to $83.00 per cwt. The CME Lean Hog Index was $90.20 on Aug. 14, up 2 cents. Specs in lean hog futures and options flipped back to a net short position by Aug. 13, totaling 2,269 contracts. Vice President Harris is set to unveil an economic agenda, including a ban on price gouging for grocery stores. USDA's FOB plant pork cutout value slipped $1.20 to $98.67 per cwt, with butt down $3.84 while picnic and rib primals rose. This week's FI hog slaughter was estimated at 2.512 million head, up from last week and a year ago. Oct, Dec, Feb hogs closed at 75.08, 67.23, and 70.98, respectively, all lower.

CapitaLand Investment edges higher ahead of Feb 11 results; focus on fundraising and logistics play

January 10, 2026, 2:41 AM EST. CapitaLand Investment Ltd (SGX:9CI) rose 1.8% to S$2.89 on Friday, with about 20.4 million shares traded, and a 2.84-2.92 range. Full-year results are due Feb 11 before the open, per an SGX notice. Ahead of the print, CLI-managed funds report: CapitaLand Malaysia Trust on Jan 28 and CapitaLand Ascott Trust on Jan 29. CLI also disclosed a S$260 million automated logistics hub via its Southeast Asia Logistics Fund, targeting completion in 2028, and a minority stake in Ally Logistic Property to operate the facility under a master lease with built-in rent increases. Investors will watch fundraising, fee income, and capital recycling into logistics. A break above last week's highs could spark short-term buying; risks include rates, trade, and project timelines.

Pre-market EUR 4.60: MLVIN.PA Foncière Vindi oversold bounce; thin liquidity and price targets

January 10, 2026, 2:29 AM EST. Foncière Vindi SA (MLVIN.PA) trades at EUR 4.60 pre-market, tracking an oversold bounce amid thin liquidity. Volume sits at 10.00 versus a 50-day average around 129.00, flagging elevated intraday volatility. Market cap about EUR 90.95 million; shares outstanding 19.77 million. The year's range mirrors the current price; the 50-day average provides a technical anchor. Fundamentals show EPS 0.07 and a trailing P/E near 65.71; BVPS EUR 1.67, implying a P/B of 2.76. Debt/Equity 0.89; interest coverage 0.30; current ratio 0.51. Meyka AI scores 64.91 (Grade: B; HOLD). Catalysts include French rental-market strength; risks include liquidity, weak coverage, and limited FCF. Trade plan: enter on volume confirming a move above 4.60 with a stop below 4.10; near-term target 4.93; conservative 5.45.

Cloudflare valuation signals overvalued after multi-year rally

January 10, 2026, 2:27 AM EST. Cloudflare's stock trades at $182.78 after a 1-year gain of 62.3% and a 5-year rise of 134.8%, with recent pullbacks of 7d -6.8% and 30d -14.4%. The year-to-date return stands at -6.8%. Investors track internet security and cloud infrastructure demand as drivers of risk and growth. Simply Wall St assigns a 0/6 valuation score, flagging limited signs of value. A DCF on a two-stage FCFE model yields an intrinsic value of about $84.54 per share, implying the stock is 116.2% overvalued. The stock also trades at a P/S of 31.80x, well above typical peers, reinforcing the valuation gap. The report suggests patience and caution about near-term upside.

Crude settles higher as Iranian protests escalate; US data support demand

January 10, 2026, 2:25 AM EST. February WTI crude settled up 2.35% and RBOB gasoline rose as unrest in Iran and government crackdowns pressed prices higher. The fourth-largest OPEC+ producer faces potential supply disruption if protests widen. The move came as upbeat US data lent support to demand: the unemployment rate fell to 4.4% and the University of Michigan sentiment index rose to 54.0. A firmer dollar capped gains later in the session. Traders eyed commodity-index rebalances that could lift oil, and demand-driven momentum from China as OPEC+ paused production hikes in Q1 2026. Saudi price cuts for February and other demand signals offered mixed ballast amid geopolitics and the energy outlook.

Nifty-gold ratio at depressed levels; investors eye potential shift back to equities

January 10, 2026, 2:09 AM EST. Gold has surged about 70% over the past year, outpacing the Nifty 50's roughly 10% gain. The Nifty-gold ratio sits near depressed levels, with Emkya Global flagging a potential move toward 5.50-4.85 as a key technical support zone. A stabilisation could signal a shift in relative strength back to equities and end the downside defensive trade. Analysts note reversals often occur near extreme zones like the 2.6-2.7 gold-to-Nifty band, but a broader pickup in growth visibility, stronger Q3 earnings, reforms transmission, and rate cuts could lift risk appetite. Emkay Global points to a long history of bullish cycles since 1991, suggesting time-based recoveries after recent corrections. The market bias remains bullish with a buy-on-dips stance amid earnings season and fiscal cues.

Sun Hung Kai (SEHK:86) valuation check after momentum; P/E signals undervalued, earnings risk noted

January 10, 2026, 1:59 AM EST. Sun Hung Kai (SEHK:86) closed at HK$4.29 amid momentum, with a 30-day return of 14.1% and a 1-year TSR of 70.4%. The stock has advanced for one and five years and sits near an analyst target of HK$6.00. On a simple P/E basis, the stock trades at 7.1x earnings, below the HK market average of 12.2x and the Asian Consumer Finance peers (14.6x). The implied fair P/E is around 7.7x, suggesting the multiple is not stretched and may move toward that level if sentiment aligns. A key risk is a 3.2% annual net income decline, with exposure to credit cycles across lending and alternative investments. Some readers may compare with fast-growing stocks with high insider ownership.

Acuity Brands Valuation Tests Pullback as Analysts Diverge on Targets (AYI)

January 10, 2026, 1:58 AM EST. AYI traded around $325.55, implying a roughly 14.5% intrinsic discount to a model value and about a 20% gap to analyst targets. Over the last month the stock fell about 13% while three-month returns are down roughly 6%, though longer-term holders remain in the black. Near-term momentum looks softer; longer horizons still point to upside if earnings power materialises. The street's consensus target sits near $340.88, with a high of $380 and a low of $275. Our fair value sits at $399.25, signaling undervaluation despite risks. Tariffs, softer volumes in key lighting channels, and any hiccups from integrating QSC into Acuity Intelligent Spaces could pressure margins and curb upside. Revenue growth, rising margins, and a smaller share count feed into the forecast.

Axon Enterprise bolsters case after Northcoast upgrade; revenue momentum and valuation diverge

January 10, 2026, 1:57 AM EST. Axon Enterprise (AXON) rose after Northcoast Research upgraded to a buy, highlighting ongoing revenue momentum and a growing subscription-based public-safety platform. At US$631.69, the stock surged 7 days by around 12.1% and 30 days by about 11.1%, even as the 90-day view sits about -10.2%. Longer horizons show a 1-year total return near 10.8%, with 3-year and 5-year multiples around 3.4x and 4.2x, underscoring gains beyond the headline upgrade. A fair value around US$822.50 suggests a valuation gap, while a DCF model puts fair value nearer US$394.56. The split signals growth optimism versus multiple pressures. Risks to the thesis include potential budget tightening and tighter privacy rules around surveillance tech that could slow product uptake.

Donnelley Financial Solutions Valuation Under Scrutiny After Momentum Move

January 10, 2026, 1:56 AM EST. DFIN is back on investors' radar as shares traded around US$51.38, with momentum visible in a 7-day and year-to-date rise but a 1-year TSR in negative territory. The stock sits about a 20% discount to a fair value estimate of US$64.33 and roughly 25% below one analyst target. The valuation case hinges on durability of growth and margins amid a secular shift toward digital, cloud-based platforms for capital markets and regulatory work. DFIN's software mix and ongoing automation investments support higher long-run margins and cash flow, but risks include a secular decline in print revenue and potential softness in capital markets activity. On earnings, the stock trades at ~42x P/E versus ~24x fair value, 25.9x industry, and 18.3x peers.

Is A. O. Smith Fairly Valued After Recent Gains?

January 10, 2026, 1:55 AM EST. At around $70.52, A. O. Smith trades with a mix of gains and growth expectations. Over the past week, interest has focused on its market positioning and how that translates into value. The stock has returned 3.2% over 7 days, 3.8% over 30 days, and 6.5% over the last year. Our valuation checks assign a 4/6 value score. A DCF model puts intrinsic value at about $86.03 a share, implying the stock is roughly undervalued by about 18% versus the current price. The latest twelve-month free cash flow stands near $571.5 million, with 2029 projections of about $663.7 million under a two-stage FCF model. The P/E ratio sits at roughly 18.5x.

Wendy's stock undervalued on DCF despite mixed long-term performance

January 10, 2026, 1:53 AM EST. Wendy's (WEN) trades at $8.65 after a 5.9% weekly gain and a 5.7% monthly rise, but the stock has piled up a mixed record: -38.6% over 12 months and declines over 3 and 5 years. Near-term headlines focus on menu innovation, store formats and franchise health in a competitive quick-service space. Our checks rate the stock 4/6 on valuation. A Discounted Cash Flow (DCF) model places an intrinsic value of about $10.39 per share, suggesting a roughly 16.7% discount to the current price, i.e., potential undervaluation on cash-flow terms. A Price-to-Earnings (P/E) view links today's price to current earnings, with fair value depending on growth expectations. The takeaway: cash-flow and earnings signals are divergent, inviting closer, risk-aware consideration.

Lululemon valuation under pressure after 48% pullback prompts reassessment

January 10, 2026, 1:38 AM EST. Lululemon athletica trades near $203.90 a share, after a 48% pullback over the past year. It rose 8.7% in the last 30 days but fell 3.3% last week as investors reassess growth and risk. On a six-check valuation framework, the stock scores 3/6. A two-stage DCF implies an intrinsic value around $192.88, placing the shares about 5.7% overvalued versus the current price. The P/E is roughly 13.7x, below some luxury peers, signaling mixed growth expectations. Cash-flow visibility and consumer demand remain key remaining drivers. Watch the brand positioning and product pipeline, and keep the name on a watchlist for clearer cash-flow visibility and a more defined risk-reward.

Commonwealth Bank of Australia stock: CBA slips as Feb 11 results loom

January 10, 2026, 1:37 AM EST. Commonwealth Bank of Australia shares closed at A$153.22, down 0.1%, about 4.5% lower for 2026. The stock trades in a A$140-A$192 52-week band. The broader ASX 200 was flat. Investors weigh rate prospects that affect NIM (net interest margin) – the profit banks earn from loans after funding costs. CBA will report its half-year results on Feb 11 and pay a interim dividend around March 30; it goes ex-dividend on Feb 18. Key catalysts: ABS spending data on Jan 12, CPI on Jan 28, and the RBA decision on Feb 3. Overseas data, including a softer US payrolls report, could move sentiment when the ASX reopens. Signs of margin pressure or higher bad debts could keep the stock under pressure before the dividend.

Penguin Solutions stock looks undervalued after weakness, DCF shows 19.8% gap

January 10, 2026, 1:22 AM EST. Penguin Solutions (PENG) closed at $19.08, with a 5.9% decline in the past week, 14.9% over the past month and 7.6% over the last year. Three-year return: 14.4%; five-year: -2.7%. Investor chatter centers on semiconductors and hardware as portfolios rebalance. Simply Wall St gives the stock a 3 of 6 valuation score. Under one valuation lens, a two-stage Free Cash Flow to Equity model yields an intrinsic value of about $23.80 per share, implying roughly a 19.8% undervaluation versus the current price. The approach uses a $104.4 million trailing FCF and forecasts $143 million in 2028. The piece also mentions the P/E approach as a quick gauge, dependent on growth and risk, but details aren't fully shown.

Chubb (CB) priced below intrinsic value after Excess Returns, P/E analysis

January 10, 2026, 1:21 AM EST. Chubb (CB) last closed at US$306.81, with a mixed momentum mix: down about 1% over the week, up 3.5% in the month, and down 1% year-to-date, yet up 20.6% over one year, 41% over three years and 113.6% over five years. The stock scores 4 of 6 on our valuation checklist. Approach 1, Excess Returns, yields an intrinsic value of roughly US$659.95 per share and an implied undervalued gap of about 53.5% versus the current price. Approach 2, Price vs Earnings (P/E) notes that a normal or fair P/E depends on growth and risk, a key discretion for insurers amid shifting sector dynamics. Taken together, the framework suggests the market is pricing in cautious earnings prospects, with earnings power and risk shaping valuation.

Logitech fair value signals undervaluation after pullback to CHF 77.34

January 10, 2026, 1:06 AM EST. Logitech International's stock pulled back after a run that left the CHF 77.34 share price trading at a discount to a proposed fair value. The 30-day return shows a -19.08% move, and year-to-date is -2.69%, while the three-year total shareholder return stands at about 59.95%. A review argues the stock is undervalued, trading below intrinsic estimates and analyst targets even as revenue and net income stay positive. Proponents point to growth from recurring software platforms (Streamlabs, G HUB), services, and deeper penetration into education and healthcare verticals, which could lift margins and cash flows over time. Risks include tariff-related cost pressure and tougher competition in gaming peripherals that could temper the anticipated uplift. A fair value around $97.73 supports a long-term upside, though investors should test assumptions themselves.

Sugar prices dip as dollar climbs; Brazil, India supply outlook weighs

January 10, 2026, 1:05 AM EST. Sugar prices slid on Friday as the dollar strengthened to a four-week high, weighing on most commodities. March NY world sugar #11 closed down 0.08 points (-0.53%), while March London ICE white sugar #5 closed down 2.00 points (-0.47%). Traders cited potential index-related buying, with Citigroup projecting inflows of about $1.2 billion into sugar futures as major indexes rebalance next week. Earlier, NY sugar touched a 2.5-month high on expectations of tighter Brazilian supply. In Brazil, Conab lifted 2025/26 production to 45 million metric tons, while Unica's data through November showed a 1.1% year-on-year rise in Center-South output to 39.904 MMT; the cane crush ratio rose to 51.12%. ISMA raised India's 2025/26 output outlook to 31 MMT, and export policy could keep shipments moving, with a 1.5 MMT quota for 2025/26.

Sugar futures slip as dollar strengthens; Brazil and India supply outlook weighs

January 10, 2026, 1:04 AM EST. March NY world sugar #11 (SBH26) fell 0.05 to a 4-week low, down 0.33%, while March London ICE white sugar #5 (SWH26) slipped 1.20, down 0.28%. A stronger dollar pushed the DXY to a four-week high, weighing on sugar and most commodities. Losses are limited by expectations of index-related buying as funds rebalance major benchmarks; Citigroup projects about $1.2 billion of inflows into sugar futures for next week's rebalancing of the BCOM and S&P GSCI indexes. The outlook remains supported by Brazil's supply outlook, with Conab raising 2025/26 production to 45 MMT from 44.5 MMT and Unica noting Center-South output up 1.1% y/y to 39.904 MMT through November. India's ISMA data show higher 2025/26 production, boosting export prospects; the ISO still sees a 1.6 million MT 2025-26 surplus, weighing on prices.

Soybeans climb at midday on export demand; WASDE preview looms

January 10, 2026, 12:52 AM EST. Soybeans are trading higher at midday, up 2 to 5¾ cents. The cmdtyView national cash price sits at $9.91. Soymeal futures rise about 30 cents; Soy oil up about 30-40 points. Overnight deliveries: 84 against January soybeans, with more on meal and oil. A private export sale of 198,000 MT to unknown destinations was reported by the USDA. USDA export data show 28.576 MMT in US soybean commitments as of 1/1, roughly 64% of the USDA projection and behind the prior year's pace. WASDE due Monday; analysts expect 2025/26 ending stocks near 295 mbu. Nearby cash remains at $9.91.

Wheat futures drift lower as export sales rise; WASDE due Monday

January 10, 2026, 12:51 AM EST. Wheat futures slipped modestly at midday, led by the Chicago SRW and KC HRW contracts, with MPLS spring wheat down 2-3 cents. The latest export data updated to January 1 shows export commitments at 20.228 MMT, up about 18% from a year earlier and near 83% of the USDA estimate, in line with the five-year average pace. Export shipments totaled 15.16 MMT, up 21% YoY and about 61% of the USDA projection, ahead of the 57% average pace. The USDA will issue a new WASDE on Monday, with ending stocks seen down about 5 mbu to 896 mbu. Market focus remains on supply/demand signals ahead of the report.

AMG valuation: fair value points to entry as shares rally

January 10, 2026, 12:50 AM EST. Affiliated Managers Group (AMG) trades at US$308.03 amid revenue of US$2,042.1m and net income of US$531.1m. Recent price action shows 1-month +10.17%, 3-month +33.47%, with 1-year TSR of 74.19% and 5-year TSR of 179.57%, prompting a fresh earnings-basis rethink. A simple narrative pegs fair value near US$345.57, suggesting AMG is undervalued at current levels. Support comes from record inflows, a 20% six-month rise in alternative AUM, and the strongest organic growth quarter in 12 years, backed by demand for yield and diversification. Valuation rests on continued appetite for higher-fee alternatives and execution at affiliates. The stock trades at P/E 16.3x vs fair 15.1x, below industry 25.9x and peer 19.2x. Entry possible but risks remain.

Roto Pumps: ROE in Line With Industry, but Growth Lag Keeps Stock Under Pressure

January 10, 2026, 12:40 AM EST. Roto Pumps Ltd. faced a 15% stock drop over the past three months as investors weigh the company's fundamentals. For the trailing twelve months to September 2025, the ROE stands at 13%-₹288 million in net profit against ₹2.3 billion of shareholder equity. That return level sits on par with the sector's 13% average but the company posted only 13% net income growth over the past five years, lagging the industry's 26% pace. The results hint at strong earnings retention or efficiency elsewhere, but earnings growth remains a concern. The piece notes the P/E ratio as a tool to gauge whether future earnings are priced in, without drawing a final verdict.

Fresnillo fair value rises on higher gold-price assumptions; JPMorgan, Citi lift targets

January 10, 2026, 12:38 AM EST. Fresnillo's fair value estimate rose to £28.64 from £24.12 as banks bake higher gold-price assumptions into models. The revision accompanies a softer discount rate (10.40% from 10.44%), stronger revenue growth (13.83% vs 10.54%), and a higher profit margin (41.13% vs 37.84%), nudging the future P/E to 15.90x (15.79x). The shift reflects a more constructive gold outlook embedded in European miners' valuations. JPMorgan and Citi have raised targets-to 4,300 GBp from 2,500 GBp and to 3,000 from 2,700 respectively-with JPMorgan keeping an Overweight rating and tying its case to an 80% lift in its long-term gold-price forecast to US$3,850/oz. Bearish calls are lacking; risk centers on how long higher gold prices persist. Investors can watch Fresnillo's fair value as gold assumptions evolve and discuss viewpoints in the Simply Wall St Community.

Aritzia climbs 12% after first billion-dollar quarter, raises FY2026 guidance (TSX:ATZ)

January 10, 2026, 12:36 AM EST.Aritzia posted its first-ever billion-dollar quarter in Q3 FY2026, delivering CA$1.04 billion in sales and CA$138.9 million in net income. The company also bought back CA$41.3 million of shares. It raised full-year net revenue guidance to CA$3.62-3.64 billion, aided by accelerated U.S. boutique expansion and digital growth. Management plans 13 new boutiques and four repositions mostly in the United States. The stock rose about 12.2% on the news. While the result underscores momentum, investors should watch whether spending on stores and marketing translates into durable profit growth. Longer-term, Aritzia projects CA$4.3 billion in revenue and CA$534 million in earnings by 2028, assuming steady growth.

Wall Financial shares rise 0.3% to C$15.93; market cap around C$509 million

January 10, 2026, 12:34 AM EST. Wall Financial Co. shares rose 0.3% Friday, trading as high as C$15.93 and last at C$15.93; volume 2,026 shares, above the 1,739-share average; prior close C$15.89. The company has a market cap of about C$509.33 million; P/E 15.47; beta 0.19. 50-day MAC$15.94; 200-day MAC$15.73. Debt-to-equity361.42; current ratio0.14; quick ratio0.10. Q4 earnings:EPSC$0.37; net margin12.82%; ROE14.98%; revenueC$48.95 million. Business: owns hotels in Metro Vancouver – Sheraton Vancouver Wall Centre and Westin Wall Centre Vancouver Airport; operates three segments: Rental, Hotel, Development.

Trump calls for one-year 10% cap on credit card interest rates

January 10, 2026, 12:23 AM EST. President Trump on Friday urged a one-year, "10%" cap on credit card interest rates, saying the public is being ripped off in a Truth Social post. The proposal, tied to the January 20 anniversary of his return to the White House, offered few details on how it would be imposed-voluntary participation or government enforcement remain unclear. He framed the move around AFFORDABILITY, blaming inflation and his predecessor for high rates. The shift marks a departure from last year, when his administration backed a Biden-era cap on an $8 fee, a policy blocked by a federal judge and opposed by banks. Critics warn caps could tighten lending access for lower-income and lower-credit borrowers in a K-shaped economy. A CNN poll shows 61% say policies worsened conditions.

Pacira Faces Activist Push as EXPAREL Growth and Buyback Drive Narrative

January 10, 2026, 12:21 AM EST. Pacira BioSciences reported preliminary unaudited 2025 revenue of $726.4 million, up from $701.0 million in 2024, as EXPAREL (Pacira's flagship postoperative analgesic) volumes hit a record peak. The company completed a $150.05 million buyback, repurchasing 5,932,106 shares since May 2025 (about 13.28% of outstanding). The setup: a business still anchored to EXPAREL, while activist investor DOMA Perpetual Capital Management pressures for board changes and a potential sale process. The buyback reinforces capital allocation focus but doesn't alter exposure to product concentration or near-term hospital adoption. The activist campaign could serve as a near-term catalyst but adds governance and execution risk if a contested board process ensues. Valuation chatter remains varied; some estimates imply upsides, others see limited scope absent product diversification.

Shilchar Technologies' 42% ROE draws attention as stock slides

January 10, 2026, 12:19 AM EST. Shilchar Technologies (NSE: SHILCTECH) has fallen about 15% in the past month even as its financials point to growth. The company's trailing ROE stands at 42% on ₹1.8 billion of net profit and ₹4.2 billion in shareholders' equity for the last twelve months through September 2025. The figure dwarfs an industry average ROE near 10%. Over five years, net income growth rose about 58%, beating the sector's ~30% pace. A low payout ratio of 8.8% suggests the firm retains most earnings to reinvest. Analysts will judge whether this profitability and retention can sustain future earnings growth, though the stock's valuation remains uncertain.

Shell seen undervalued after price weakness, DCF model shows large valuation gap

January 10, 2026, 12:15 AM EST.Shell's London-listed shares closed at £26.40, slipping 4.3% on the week and slightly over the month, with a year-to-date drop of 4.3% and a 1-year gain of 4.7%. Its longer horizons look healthier: 3-year and 5-year returns are 22.0% and 116.6%, respectively. The stock carries a valuation score of 4 out of 6, suggesting it screens as undervalued on most checks. In a Discounted Cash Flow (DCF) setup using a 2-stage Free Cash Flow to Equity model in US$, the latest trailing FCF is US$27.95b, with 2030 estimates near US$30.25b, yielding an intrinsic value of US$85.10 per share. At £26.40, the model implies the stock is about 69.0% undervalued. Caution remains on long-term cash-flow assumptions.

Kawasaki Heavy Industries valuation in focus after strong price momentum (TSE:7012)

January 10, 2026, 12:13 AM EST. Kawasaki Heavy Industries (TSE:7012) has posted strong price momentum, up about 27% in three months, with a 7-day gain of 19.2% and a 1-year total shareholder return near 78%. The stock trades at ¥12,370, versus a narrative fair value around ¥12,975, suggesting a modest upside under that framework. Analysts' average target sits near ¥13,433, while a separate SWSDCF model puts fair value at about ¥6,858, implying the stock could be overvalued under that scenario. Drivers include rising aerospace orders, cost-control gains, and a global air-travel recovery. Risks include potential pressure on free cash flow and currency effects from yen swings. The story hinges on how assumptions about revenue growth, margins, and the path to earnings power align over the next few years.

Fiverr International stock slides amid valuation gap as earnings loom

January 10, 2026, 12:11 AM EST. Fiverr International shares fell 7.05% after a day when broader markets rose, fueling focus on the upcoming earnings and growth outlook. The drop compounds a 7.83% year-to-date decline and a 42.96% 1-year total shareholder return loss, signaling fading momentum amid higher EPS and revenue expectations. With the stock near $18.14, analysts flag a forward P/E below peers and a valuation gap versus targets. Bejgal puts Fiverr's fair value at $43.33, highlighting a wide disconnect to the latest close. Revenue growth is expected to remain robust on high-margin services and a rising take rate, while margins could improve as SaaS-like offerings expand and efficiency programs take hold. Risks include weak SMB sentiment and a softer professional staffing market.

SPS Commerce valuation under review after momentum shift; DCF and narrative fair value diverge

January 10, 2026, 12:09 AM EST. SPS Commerce (SPSC) has attracted attention as momentum shifts unfold. In the past week the stock rose 7.5% and in the past month 10.2%, yet 90-day performance fell 11.6% while 1-year and 5-year returns remain positive at 47.3% and 11.7%, signaling fading momentum at longer horizons. The shares trade modestly below a consensus price target, while the narrative fair value sits near $98 per share. A separate DCF model yields about $126.05, widening the valuation gap. Analysts' targets span $120 to $170, with a consensus around $152.36. Slower supplier tech spending and customers trimming SPS invoices could cap upside. Investors may stress test assumptions or broaden their watchlists to test different growth scenarios.

ASICS Valuation Comes Into Focus After Strong Run; DCF Signals Overvaluation

January 10, 2026, 12:07 AM EST.ASICS, trading at ¥4,142, rose 3.55% in the latest session as investors weigh valuation against returns. The stock has delivered a 1-year total shareholder return of 28.37% and a long run of gains over five years. On a P/E basis, ASICS at 34.5x sits well above peers; the peer average is 14.5x, with a fair P/E around 24.5x and the JP Luxury sector averaging 15.2x. A DCF model points to a fair value of ¥3,215.31, suggesting the market is pricing in stronger growth than the model implies. If sentiment cools, multiples may compress. Investors may consider adding ASICS to a watchlist while weighing earnings growth risks.

Nat-Gas prices sink as warm US weather forecasts dampen demand

January 10, 2026, 12:05 AM EST. Feb Nymex natural gas (NGG26) closed down 0.238, or 6.99%, to a 2.5-month low as forecasts for warmer US weather curb heating demand and support storage buildup, according to NatGasWeather for Jan 9-15 and 16-23. The broader backdrop remains bearish for prices: the EIA raised its 2025 US production forecast to 107.74 bcf/d, while Lower-48 dry gas output ran 113.5 bcf/d and demand was 87.9 bcf/d, per BNEF data. LNG net flows to US terminals were 19.5 bcf/d. Electric output rose 6.7% y/y in the week to Jan 3, with a 52-week gain of 3.0%. The EIA weekly inventory showed a -119 bcf draw for the week ended Jan 2, well above forecasts. European storage was 58% full vs 72% seasonal average. Baker Hughes counted 124 active US nat-gas rigs for the week to Jan 9.

Lean Hogs Slip on Friday as Prices Edge Lower

January 10, 2026, 12:03 AM EST. Lean hog futures were trading lower on Friday, with losses of 10 to 60 cents. The USDA's national base hog price was reported at $68.56 per cwt in Friday morning quotes. The CME Lean Hog Index fell 27 cents to $80.98 on Jan. 7. The USDA's pork carcass cutout value rose $4.94 to $95.73 per cwt, with all primals higher and the belly up $12.17. USDA estimated federal hog slaughter for Thursday at 496,000 head, bringing the week-to-date total to 1.977 million head, up 73,159 head versus the same week last year. Traders will watch demand data and export pace as supplies stay ample and margins compress.